CURRICULUM VITAE Russell H. Samson, M.D., R.V.T., …veinsandarteries.com/cosmetic/cv/cv_samson.pdf · Bronx, New York 1974-1979 - Surgery ... Illuminati, G.; Contributing Author,

CURRICULUM VITAE Russell H. Samson, M.D., R.V.T., F.A.C.S.

NAME: Russell Howard Samson OFFICE: Sarasota Vascular Specialists 600 North Cattlemen Road, Suite 220 Sarasota, Florida 34232 Telephone: (941) 371-6565 Facsimile: (941) 377-7731 eMail: [email protected] RESEARCH OFFICE: 1540 South Tamiami Trail, 3rd Floor Sarasota, FL 34239 DATE OF BIRTH: March 15, 1950 PLACE OF BIRTH: Johannesburg, South Africa CITIZENSHIP: U.S.A. MARITAL STATUS: Married with two children Wife: Susan HIGH SCHOOL: Parktown Boys’ High School, Johannesburg, South Africa MEDICAL SCHOOL: University of the Witwatersrand, Johannesburg, South Africa, 1967-1972 INTERNSHIP: Medicine: Professor Zwi's Unit, January 1973 to July 1973, Johannesburg General Hospital Surgery: Professor D.J. du Plessis's Professorial Unit, July 1973 to December 1973, Johannesburg General Hospital LOCUM TENENS: London - January to June 1974 RESIDENCY: Albert Einstein College of Medicine Bronx, New York 1974-1979 - Surgery CHIEF RESIDENCY: Albert Einstein College of Medicine, Bronx, New York 1978-1979 - Surgery

mailto:[email protected]

CURRICULUM VITAE

RUSSELL H. SAMSON, M.D., F.A.C.S.

Page -2-

MILITARY SERVICE: Not applicable FELLOWSHIP: Clinical Fellow in Vascular Surgery: 1979-1980 Montefiore Medical Center, Bronx, N.Y. Associate Professor of Surgery Albert Einstein College of Medicine, Bronx, New York LICENSES: California, #C55203, 2012 Registered Vascular Technician, 1997 Florida, #0049137, August 4, 1986

New York State, #130115, February 25, 1977 South African Medical & Dental Council, #153561856, December 19, 1973 Educational Council for Foreign Medical Graduates, #1852896, July 26, 1972 BOARD CERTIFICATION: Diplomate of the American Board of Surgery, #26124, 8-24-80; Recertified October 21, 1988. Diplomate of the American Academy of Wound Management, Certified

Wound Specialist, April 2002 - 2003

Certificate of Special Competency in Vascular Surgery, issued by the American Board of Surgery, #314, November 18, 1983; Board Vertified in Vascular Surgery, January 1994; Recertified October 2003, Recertified September, 2014

AWARDS: SVS Volunteerism Award, First recipient, Society for Vascular Surgery

Meeting 2011

2010 Patients’ Choice Award

CURRICULUM VITAE


Page -3-

Physician’s Recognition Award – American Medical Association- Physicians dedicated to the health of America - June 1, 1999 – June 1, 2002 Founding Member – Florida Vascular Society, 1988 Distinguished Fellow of the Society for Vascular Surgery, June 9, 2003

MOTE VASCULAR FOUNDATION: President, 1998 – current

HONORS: Castle Connolly America’s Top Doctors 2009, 2010, 2011, 2012, 2013, 2014 The Best Doctors in America® Listing for 2011-2013 (selected by peers)

Guide to America’s Top Surgeons Listing for 2011

American Registry’s 2011 & 2012 Patients’ Choice Awards The Best Doctors in America® Listing for 2011-2012 (selected by peers)

Young Investigator’s Award Judging, Society for Vascular Ultrasound’s 28th Annual Conference, June 17, 2005

Co-Chairman Lower Extremity Ischemia I – 24th World Congress of the ISCVS, September 23, 1999 – Melbourne, Australia

Member (Distinguished Fellow), Society for Vascular Surgery, 1999 Florida Vascular Society (President -2001), 1997 to 2000

Co-Chairman Carotid Artery Surgery Section - 23rd World Congress of the ISCVS, September 22, 1997 – London, England

Guest Speaker, 76th Congress on Medical Education, Chicago, 1977

Cottrell Memorial Prize for academic excellence and contribution to student affairs, 1972

Vice-President for Africa, International Federation of Medical Student Associations, 1971

CURRICULUM VITAE


Page -4-

President - Association of Medical Students of South Africa, 1970-1971 Treasurer - Students Medical Council, 1969 EDITORIAL POSITIONS: Medical Editor – Vascular Specialist – the official newspaper of the Society for Vascular Surgery; 2013 – current. Assistant Editor – Vascular Surgery, 6th Edition, Edited by Robert B.

Rutherford – W.B. Saunders Company, Publishers, 2005. Section 7 Nonoperative Management of Patients with Vascular Diseases, pp 579-639

Editorial Board – Vascular Specialist (current)

Editorial Board – Vascular News (current) Editorial Board – Optimal Aging Report (current) Editorial Board – Vascular (current) Section Editor – Vascular & Endovascular Surgery (current) Editorial Board, Dermatologic Surgery (current) Reviewer – British Medical Journal 2012 – Reviewer – Acta Neuroligica Scandinavia, 2009 - Reviewer – Journal of Vascular Surgery, 2000 - Editorial Board, Vascular Laboratory Review, 1984 -

Consultant Editor “Journal of International Physicians”, 1977 - Issue Editor, Seminars in Vascular Surgery; 2008. Issue Editor, Seminars in Vascular Surgery; 2002.

CURRICULUM VITAE


Page -5-

HOSPITAL & TEACHING APPOINTMENTS: ACTIVE Clinical Professor of Surgery (Vascular) Department of Clinical Sciences Florida State University Medical School, 2007 to present Staff Member Doctors Hospital of Sarasota Sarasota, Florida September 1986 to present Staff Member Sarasota Memorial Hospital Sarasota, Florida September 1986 to present Staff Member Lakewood Ranch Medical Center Bradenton, Florida December 2014 to present

PAST Chief of Surgery Section Sarasota Memorial Hospital November 1994 to November 1995

Chief of Surgery Section Doctors Hospital, 1990-91

Associate Professor of Surgery Albert Einstein College of Medicine June 1986 to September 1986 Vascular Surgeon-in-Charge Bronx Municipal Hospital Center August 1982 to September 1986

Clinical Instructor in Surgery Albert Einstein College of Medicine July 1980 to November 1980

CURRICULUM VITAE


Page -6-

Assistant Professor of Surgery Albert Einstein College of Medicine November 1980 to June 1986 Attending Surgeon Bronx Municipal Hospital Center 1980 to September 1986 Director - Vascular Laboratories Montefiore Medical Center- Albert Einstein College of Medicine 1980 to September 1986 Attending Surgeon Montefiore Medical Center 1980 to September 1986 Attending Surgeon Hospital of the Albert Einstein College of Medicine 1980 to September 1986 Attending Surgeon North Central Bronx Hospital 1980 to September 1986 HOSPITAL, UNIVERSITY & SOCIETY COMMITTEES: Secretary/Treasurer – Florida Vascular Foundation Scholarship Fund – 2013- Chairperson – Clinical Events Committee – FDA Review Panel for a Novel Aortic Endograft Society for Vascular Surgery Focus Group – The GreenRoom Project – 2011- Society for Vascular Surgery Document Oversight Committee – 2011 - Clinical Practice Council for Society for Vascular Surgery – 2009-2012 Vice President Florida Vascular Foundation Board – 2008 -

CURRICULUM VITAE


Page -7-

Chairperson, Community Practice Advisory Committee for Society for Vascular Surgery – 2008-2009

Director, Non-Invasive Lab Sarasota Memorial Hospital, 2002 - Chairman, Outcome Committee, American Association for Vascular Surgery 2000 Executive Member

Heart & Vascular Center of Florida, Sarasota, 2000 to June 2001 Medical Executive Sarasota Memorial Hospital, 1998- 2006 Chairman, Surgical Evaluation Committee Sarasota Memorial Hospital, 1995 - 1997 Surgical Suite Committee Sarasota Memorial Hospital, 1995 – 1996 Medical Director Wound Care Center at Doctor’s Hospital of Sarasota,

1994 – 2002 Medical Advisory Board Heartland Wound Care Center, 1994 - 1998 Board of Directors Temple Beth Shalom, 1994 - 1996 Chairman, Department of Surgery Sarasota Memorial Hospital, 1994 - 1995 Chairman, Surgical Privileges Committee Sarasota Memorial Hospital, 1994 - 1995 Surgical Suite Committee Sarasota Memorial Hospital, 1993-Present Medical Executive Committee Sarasota Memorial Hospital, 1993-1994, 1998-

CURRICULUM VITAE


Page -8-

Board of Trustees Doctors Hospital, 1989 Surgical Audit Committee Doctors Hospital, 1988 Surgical Quality Assurance Committee Sarasota Memorial Hospital, 1988 Credentials Committee, Doctors Hospital, 1988 Blood Usage Committee Sarasota Memorial Hospital, 1987

Member, Patent Committee, Albert Einstein College of Medicine, 1984 to September 1986

Senator Albert Einstein College of Medicine, 1983 to September 1986 Delegate to the Resident Section of the AMA, 1975-1977

Representative to the Educational Council for Foreign Medical Graduates (ECFMG), joint appointment by the AMA & PNHA, 1975-1977

Vice-President for Foreign Medical Graduates, Physicians National Housestaff Association (PNHA), 1975-1977

Delegate - Committee of Interns & Residents, 1974-1976 President - Association of Medical Students of South Africa, 1970-1971 Treasurer - Students Medical Council, 1969 PROFESSIONAL SOCIETIES: Founding Member – International Society for Vascular Surgery, 2004 American Venous Forum, February 2001 - President, Florida Vascular Society, 2001-2002

CURRICULUM VITAE


Page -9-

Member (Distinguished Fellow), Society for Vascular Surgery, 1999 Florida Vascular Society (President -2001), 1997 to 2000

European Society for Vascular Surgery, 1996 -2002

North American Society of Phlebology, 1995 Charter Member - International Society for Endovascular Surgery, 1993 Southern Association for Vascular Surgery, 1989 to present

Founding Member-Florida Vascular Society, 1988 Society for Clinical Vascular Surgery, 1987 to present International Society for Cardiovascular Surgery, 1985 American Association for Vascular Surgery, 1985

Fellow of the American College of Surgeons, 1983 to present New York Regional Vascular Society, 1983 to 1988

New York Surgical Society, 1983 to 1988 Vascular Society of New Jersey, 1982 to 1988 Society for Vascular Ultrasound, 1981 to present

Association for Academic Surgery, 1981

New York Society for Cardiovascular Surgery, 1981 to 1988

CONSULTANT APPOINTMENTS: Consultant – Johnson and Johnson, 2006 to 2007 Consultant – Medtronic Advisory Board, 2006 to 2008 Consultant - Advisory Working Group on Comprehensive Stroke Centers, 2005 to present

CURRICULUM VITAE


Page -10-

Consultant – Angiodynamics, 2004 -2007 Consultant – Medical Advisory Board – Boston Scientific, 2004 -2006

Consultant – Jobst, 1988 to 2002

Consultant - Ultrasonics, 1985 - 1986

Consultant - Multigon Industries, 1985 – 1986

The Society for South African Surgeons and Gynecologists of North American, Secretary, 1980 to present

RESEARCH GRANTS: Jobst Foundation: Investigation of venous pathophysiology. Reed Lignin: Investigation of blood coagulation. WORK HISTORY: 1986 to present: Vascular Surgeon, Sarasota Florida 1980-1986: Vascular Surgeon, Bronx New York PUBLICATIONS: I. PRINTED IN PEER-REVIEWED JOURNALS

1. Samson RH, Morales R, Showalter DP, Lepore MR Jr, Nair DG, Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison; Journal of Vascular Surgery, September 2016 (Vol 64, No 3, pp 638-647)

2. Singh MJ, Fairman R, Anain P, Jordan WD, Maldonado T, Samson RH, Makaroun MS Final results of the Endurant Stent Graft System in the United States regulatory trial; Journal of Vascular Surgery, July 2016 (Vol 64 number 1,pp 55-62)

3. Silverman SH, Exline JB, Silverman LN, Samson RH, Endovascular brachytherapy for renal artery in-stent restenosis; December, 2014; Journal of Vascular Surgery (Vol 60, Issue 6, pp 1599-1604)

4. Satiani B, Nair D, Starr J, Samson, RH, Essentials of negotiating for employment in a changing environment; March, 2014; Journal of Vascular Surgery (Vol, pp 1-7)

CURRICULUM VITAE


Page -11-

5. Samson RH, Cline JL, Showalter DP, Lepore ML, Nair DG, Contralateral carotid artery occlusion is not a contraindication to carotid endarterectomy even if shunts are not routinely used; October, 2013; Journal of Vascular Surgery; (Vol. 58, Issue 4, pp 935-940)

6. Samson, RH, Part Two: Against the Motion. Completion Angiography is Unnecessary Following Carotid Endarterectomy; May, 2013; European Journal of Vascular & Endovascular Surgery; (Vol. 45, Issue 5, pp 420-422.)

7. Samson, RH; Riccio, JB; Schneider, F.; Illuminati, G.; Contributing Author, The Role of Completion Imaging Following Carotid Endarterectomy, March, 2013; co-published in the Journal of Vascular Surgery and the European Journal of Vascular and Endovascular Surgery. (Vol. 75, Issue 5, pp 1432-1438.)

8. Samson, RH, External Reviewer. Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial, July 10, 2012, Journal of the American College of Cardiology (Vol. 59, No. 26)

9. Samson, RH, Can Pharmacologic Agents Slow Abdominal Aortic Aneurysm Growth? March, 2012, Seminars in Vascular Surgery (Vol. 25-1; 25)

10. Samson, RH, Nair, D.G., Influence and Critique of the JUPITER Trial (Statins v. No Statins for Primary Prevention of Cardiovascular Events in Patients with Normal Lipids and Elevated C- Reactive Protein), September, 2011, Seminars in Vascular Surgery, (Vol. 24, pp172-179)

11. Samson, RH, Private Practice Perspective on Recent Conflict of Interest Mandate, September 2011, Journal of Vascular Surgery 2011;54:15S-8S

12. External reviewer: Peripheral Vascular Ultrasound and Physiological Testing Appropriate Use Criteria document for the American College of Cardiology 2010

13. Samson, RH, Showalter DP, Lepore Jr MR, Lanoue J, Nair, DG, Long-term Safety of Renal Vein Division and Ligation to Expedite Complex Abdominal Aortic Surgery. September 2009, Journal of Vascular Surgery (Vol. 50;3); 500-504

14. Samson, RH, Setting up an Imaging Center, Adding Computed Tomographic, Magnetic Resonance,

and An Angiography Suite to Vascular Labs. April 2009, Journal of Vascular Surgery (Vol. 49;4); 1073-1076

15. Schanzer A, Mega J, Meadows J, Samson, RH, Bandyk D.F., Conte M.S. Risk Stratification in Critical

Limb Ischemia: Derivation and Validation of a Model to Predict Amputation-Free Survival Using Multicenter Surgical Outcomes Data. December 2008, Journal of Vascular Surgery (Vol. 48-6); 1464-1471

16. Samson, RH , Setting up an Outpatient Imaging Center: Adding Computed Tomographic

Angiography, Magnetic Resonance Angiography and an Outpatient Angiography Suite to Surgeon-

CURRICULUM VITAE


Page -12-

Run Vascular Laboratories, December 2008, Perspectives in Vascular Surgery and Endovascular Therapy (Vol. 20-4); 333-338; with Commentary R. Clement Darling III, MD; Last Word Russell H. Samson, MD

17. Samson, RH , Showalter DP, Lepore M, Nair DG, Merigliano K, Cryoplasty Therapy of the Superficial

Femoral and Popliteal Arteries: A Reappraisal After 44-Months’ Experience, Journal of Vascular Surgery, 2008; 48;634-637

18. Samson, RH, Introduction – Risk Factors in Vascular Disease: Who is Really at Risk and What

Can Be Done About It? , Seminars in Vascular Surgery, 2008;21;117-18 19. Nair DG, Samson, RH, Which Diabetics are at Risk for Lower-Extremity Problems and What

Preventive Measures Can Be Taken? , Seminars in Vascular Surgery, 2008;21;154-159 20. Samson, RH, Have Statins Changed the Natural History of Atheromatous Disease and Its

Treatment? Seminars In Vascular Surgery, 2008;21;160-164 21. Kessel DO, Samson, RH, What is the Evidence for the Efficacy of Cryoplasty? Journal of

Cardiovascular Surgery, 2008;49:179-85 22. Samson, RH, The Role of Statin Drugs in the Management of the Peripheral Vascular Patient –

Vascular and Endovascular Surgery, Volume 42-4, August/September 2008;352-366 23. Samson, RH, Showalter D.P., Lepore Jr. M.R., Ames S; Cryoplasty Therapy of the Superficial

Femoral and Popliteal Arteries: A Single Center Experience, Vascular and Endovascular Surgery, December/January 2007, Volume 40, Number 6:446-450

24. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy

SP, Belkin M, Berceli SA, DeMasi RJ, Samson, RH, Berman SS; PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006 Apr;43(4):742-751

25. Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL, Hamdan AD, Roddy SP, Belkin

M, Berceli SA, DeMasi RJ, Samson, RH, Berman SS. Perspective multi-center study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 2006; 44:977-84.

26. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Hamdan AD, Roddy SP, Belkin M, Berceli

SA, DeMasi RJ, Samson, RH, Berman SS for the PREVENT III Investigators. Results of PREVENT III: a multi-center, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2005; 43:742-751.

CURRICULUM VITAE


Page -13-

27. Samson, RH, Periprocedural Hypertension: Current Concepts in Management for the Vascular Surgeon, Vascular and Endovascular Surgery, July/August 2004, Volume 38, Number 4:361-366

28. Samson, RH, Yungst, Z, Showalter, D.P., Homocysteine, a risk factor for carotid atherosclerosis, is not

a risk factor for early recurrent carotid stenosis following carotid endarterectomy, Vascular and Endovascular Surgery, July/August 2004, Volume 38, Number 4:345-348

29. Samson, RH, Showalter, D.P., Persistent Sciatic Artery as Collateral for an Occluded Iliofemoral

System, Journal of Vascular Surgery, July 2004, Volume 40, Number 1:183 30. Samson, RH, Hypertension and the Vascular Patient, Vascular and Endovascular Surgery, March-April

2004, Volume 38, Number 2:103-119 31. Samson, RH, Introduction to a New Vascular Medicine Section, Vascular and Endovascular

Surgery, March-April 2004, Volume 38, Number 2:101-102 32. Samson, RH, Nonoperative Management of Patients With Vascular Conditions, Miscellaneous

Medications for the Management of Atherosclerosis: Mayhem or Miracle?, Seminars In Vascular Surgery, Volume 15;(4) December 2002,275-287

33. Stanley, James C, Samson, RH, Nonoperative Management of Patients With Vascular Conditions, Treatment of Hypertension From Volume to Vasoconstriction: The ACE Up Your Sleeve, Seminars In Vascular Surgery, Volume 15;(4) December 2002, 225-236

34. Samson, RH, Nonoperative Management of Patients With Vascular Conditions, Pharmaceutical

Initiatives to Combat Atherosclerosis – What To Do With the Good, the Bad, and the Ugly Lipoproteins, Seminars In Vascular Surgery, Volume 15;(4) 2002,204-215

35. Samson, RH, Nonoperative Management of Patients With Vascular Conditions, Overview,

Seminars In Vascular Surgery, Volume 15;(4) 2002, 275-287

36. Samson, RH, Showalter, D.P., A selective approach to heparin use during elective abdominal aortic aneurysm resection: Techniques, precautions and advantages. Ann Vasc Surg, 2002; 16:279-285

37. Samson, RH, Femoropopliteal bypass is not a generic procedure. A survey of the practice

patterns of The Florida Vascular Society. Ann Vasc Surg, 2001; 15: 544-547 38. Samson, RH, Spindel, J., Gil, K., Perna, T., Barngrover, J., Showalter, D.P., Yunis, J.P., Silverman, S.,

Dorsay, D., Kulman, H.L., Risk factor analysis increases efficacy of duplex screening programs for carotid plaque. Journal of Vascular Technology, 24(2):113-116, 2000

CURRICULUM VITAE


Page -14-

39. Samson, RH, Bandyk, D.F., Showalter, D.P., Yunis, J.P., Carotid endarterectomy based on duplex ultrasonography: A safe approach associated with long-term stroke prevention. Vasc. Surg; 34: 125- 136, 2000

40. Samson, RH, Showalter, D.P., Yunis, J.P., Dorsay, D. A., Kulman, H.I., Silverman, S.R.,

Hemodynamically significant early recurrent carotid stenosis: an often self-limiting and reversing condition. J Vasc. Surg; 30: 445-447, 1999

41. Samson, R H., Showalter, D. P., Yunis, J. P., Buselli, K., and Perna, T., Color flow scan diagnosis of

carotid string sign may prevent unnecessary surgery. Cardiovasc Surg; 7:236-241, 1999 42. Samson, RH, Showalter, D. P., Yunis, J. P., Isolated femoro-popliteal bypassgraft for limb salvage after

failed tibial reconstruction: A viable alternative to amputation. J Vasc Surg; 29:409-412, 1999 43. Samson, RH, Showalter, D. P., Yunis, J. P., Routine Carotid Endarterectomy without a shunt

even in the presence of a contralateral occlusion. Cardiovasc Surg; 6:475-484, 1998 44. Samson, RH, Yunis, J. P., Showalter, D.P., Is Thigh Saphenectomy a necessary adjunct to high ligation

and stab avulsion phlebectomy? American Journal of Surgery; 176:168-171, 1998 45. Samson, RH, Showalter, D. P, Stockings and the Prevention of Recurrent Venous Ulcers.

DermatolSurg; 22:373-376, 1996 46. Samson, RH: Compression stockings and non-continuous use of polyurethane foam dressings for the

treatment of venous ulceration. Dermatol Dig, June 1994 47. Samson, RH: Compression stockings and non-continuous use of polyurethane foam dressings for the

treatment of venous ulceration. - A Pilot Study. J Dermatol Sur Oncol; 19:68-72, 1993 48. Friedell, M., Samson, RH, Cohen, Michael J., Simmons, Gregory T., Rollins, David L., Mawyer,

Laura and Semrow, Carolyn M.: High ligation of the greater saphenous vein for treatment of lower extremity varicosities: The fate of the vein and therapeutic results. Ann Vasc Surg 6: 1, 5-8, 1992

49. Samson, RH, Willis, Paul A.: Popliteal artery occlusion due to cystic adventitial disease; successful

treatment by urokinase followed by non-resectional cystotomy. J Vas Surg 591-593, 1990 50. Samson, RH, Veith, Frank J., Janko, Gary S., Ascer, Enrico, Gupta, Sushil K., and Scher, Larry A.: A

Modified Classification and new approach to the management of infections involving peripheral arterial prosthetic grafts (PAPG). J Vasc Surg 8:147-153, 1988

51. White, R.A., Scher, L.A., and Samson, RH: Peripheral Vascular injuries associated with falls from

heights. J. Trauma 27:411-414, 1987

CURRICULUM VITAE


Page -15-

52. Scher, L.A., Veith, F.J., White, R.A., Ascer, E., Gupta, S.K., Samson, RH and Sprayregen, S.: Limb salvage in octogenarians and nonagenarians, Surg 99:160, 1986.

53. Veith, F.J., Gupta, S.K., Ascer, E., White-Flores, S.A., Samson, RH, Scher, L.A., Towne, J.B.,

Bernhard, V.,Bonner, P., Flinn, W.R., Astelford, P.M., Yao, J.S.T., Bergan, J.J.: Six-year perspective multicenter randomized comparison of autologous saphenous polytetrafluoro-ethylene grafts in infrainguinal arterial reconstruction, J Vasc Surg 3:104-114, 1986.

54. Scher, L.A., Samson, RH, Ketosugbo, A., Gupta,S.K., Ascer, E.,Veith, F.J.: Prevention and management

of ischemic complications of vein harvest incisions in cardiac surgery, Angiology 37:119-123, 1986. 55. Samson, RH, Scher, L.A., Gupta, S.K., Ascer, E. and Veith,F.J.: Photoplethysmographic evaluation

of external compressive therapy for chronic venous ulceration. J Cardiovasc Surg 27:24-26, 1986. 56. Scher, L.A., Veith, F.J., Samson, RH, Ascer, E., Gupta, S.K.: Vascular complications of thoracic

outlet syndrome. J Vasc Surg 3:565-568, 1986. 57. Ascer, E., Veith, F.J., Samson, RH, Gupta,S.K., Scher, L.A., Stein, T.L. and White-Flores, S.A.:

Collateral back pressure (CBP): Is it a valid predictor of infrainguinal bypass graft patency? J. Surg Res 38:453-460,1985.

58. Ascer, E., Veith, F.J., Gupta, S.K., Samson, RH, Scher, L.A., White-Flores, S.A., Sprayregen, S. and

Fell, S.C.: Six year experience with 867 expanded polytetrafluoro-ethylene arterial grafts for limb salvage. J Cardiovasc Surg 26:468-472, 1985.

59. Veith, F.J., Ascer, E., Gupta, S.K., White-Flores, S., Sprayregen, S., Scher, L.A. and Samson, RH:

Tibiotibial vein bypass grafts: a new operation for limb salvage. J Vasc Surg 2:552-557, July 1985. 60. Samson, RH, Scher, L.A. and Veith, F.J.: Combined segment arterial disease, Collective Review

Section, Surgery 97:385-397, April 1985 61. Samson, RH, Gupta, S.K., Veith, F.J., Ascer, E. and Scher, L.A.: Perioperative Noninvasive

Hemodynamic Parameters As Predictors of Infrainguinal Graft Patency. J. Vasc Surg 2:307-311, March 1985.

62. Ascer, E., Veith, F.J., Gupta, S.K., Scher, L.A., Samson, RH, White-Flores, S.A. and Sprayregen, S.:

Comparison of axillounifemoral and axillobifemoral bypass operations. Surgery 97:169-175, 1985. 63. Veith, F.J., Weiser, R.K., Gupta, S.K., Scher, L.A., Samson, RH, Ascer, E., White-Flores, S.A. and

Sprayregen, S.: Diagnosis and management of failing lower extremity arterial reconstructions prior to graft occlusion, J. Cardiovasc Surg 25:381-384, 1984.

CURRICULUM VITAE


Page -16-

64. Ascer, E., Veith, F.J., Morin, L., White-Flores, S.A., Scher, L.A., Samson, RH, Weiser, R.K., Rivers, S., and Gupta, S.K.: Quantitative assessment of outflow resistance in lower extremity arterial reconstructions. J. Surg Res 37:8-15, 1984.

65. Ascer, E., Veith, F.J., Morin, L., White-Flores, S.A., Samson, RH, Scher, L.A., Rivers, S.P. and Gupta,

S.K.: Components of outflow resistance and their correlation with graft patency in lower extremity arterial reconstructions. J. Vasc Surg 1:817-828, November 1984.

66. Ascer, E., Krasowski, G., Veith, F.J., Gliedman, M.L., Scher, L.A., Samson, RH and Gupta, S.K.: Are

composite PTFE/vein bypass grafts superior to those of PTFE alone? Surgical Forum 35:425-427, 1984.

67. Gupta, S.K., Veith, F.J., White-Flores, S.A., Samson, RH, Scher, L.A., Weiser, R.K. and Ascer, E.: A

system for widespread application of microcomputers to vascular surgery, J Vasc Surgery 1:601-604, July 1984.

68. Samson, RH, Rhodes, B.,Grossman, D., and Gonzalez, E.: Evaluation of graft patency utilizing

ankle brachial pressure index and pulse volume recording amplitude, Bruit 8:179-180, June 1984. 69. Rhodes, B., Grossman, D., Gupta, S.K., Weiser, R.K., Veith, F.J., and Samson, RH: Improved technique

for the diagnosis of vasculogenic impotence, Bruit 8:171-173, June 1984. 70. Scher, L.A., Veith, F.J., Haimovici, H., Samson, RH, Ascer, E., Gupta, S.K. and Sprayregen, S.:

Staging of arterial complications cervical rib: Guidelines for surgical management, Surgery 95:644-649, June 1984.

71. Samson, RH, Gupta, S.K., Veith, F.J., Scher, L.A. and Ascer, E.: Evaluation of graft patency utilizing

ankle brachial pressure index and ankle pulse volume recording amplitude, Am J Surg 147:786-787, June 1984.

72. Samson, RH, Gonzalez, E., Rhodes, B., Grossman, D., Veith, F.J., Scher, L.A., Gupta, S.K., and Ascer, E.

Photoplethysmographic evaluation of external compressive therapy for chronic venous ulceration, Bruit 8:23-25, March 1984.

73. Samson, RH, Sprayregen, S., Veith, F.J., Gupta, S.K., and Scher, L.A.: Inadequacy of the hemodynamic

evaluation of percutaneous transluminal angioplasty, Am J Surg 147:212-215, February 1984. 74. Samson, RH, Sprayregen, S., Veith, F.J., Scher, L.A., Gupta, S.K. and Ascer, E.: Management of

angioplasty complications, unsuccessful procedures and early and late failures, Ann Surg 199:234-240, February 1984.

75. Samson, RH, Scher, L.A., Gupta, S.K. and Veith, F.J.: Absence of a Venous Cause for Erection: A

plethysmographic study, Surgical Forum 34:666-667, October 1983.

CURRICULUM VITAE


Page -17-

76. Samson, RH, Gupta, S.K., Scher, L.A., and Veith, F.J. Limb-threatening vascular disease in patients

with coincidental malignancy - An approach to management. Cancer 52:1126-1128, 1983. 77. Samson, I.D., and Samson, RH: Technical aid for the obstinate embolectomy. Arch Surg 118:770-

771, 1983. 78. Samson, RH, Rhodes, B., Grossman, D. and Veith, F.J.: Evaluation of graft patency utilizing a

transcutaneous PO2 sensor. Bruit 7:27-29, 1983. 79. Bergan, J.J., Veith, F.J., Bernhard, V.M., Yao, J.S.T., Flinn, W.R., Gupta, S.K., Scher, L.A.,

Samson, RH and Towne, J.B.: Randomization of autogenous vein and polytetra-fluoroethylene (PTFE) grafts in femoro-distal reconstruction, Surgery 92:921-930, 1982.

80. Scher, L.A., Samson, RH, Goldstein, R.D., Gupta, S.K., and Veith, F.J.: Accelerated atherosclerosis

in a tortuous iliac artery following femorofemoral bypass, Vas Surg 16:296-301, 1982. 81. Samson, RH, Gupta, S.K., Scher, L.A., and Veith, F.J.: Fallibility of intra-operative gram stain in the

diagnosis of vascular infections, Angiology 33:680-684, 1982. 82. Samson, RH, Gupta, S.K., Scher, L.A., and Veith, F.J.:Arterial spasm complicating distal vascular

bypass procedures, Arch Surg 117:973-975, July 1982. 83. Samson, RH, Gupta, S.K., and Veith, F.J.: Level of amputation after failure of limb salvage procedures,

Surg Gynecol Obstet 154:56-58, January 1982. 84. Samson, RH, Gupta, S.K., Scher, L.A., and Veith, F.J.: Treatment of limb-threatening ischemia despite

a palpable popliteal pulse, J Surg Res 32:535-539, 1982. 85. Samson, RH, Rhodes, B.A., Grossman, D.S., Sprayregen, S., and Veith, F.J.: Evaluation of the

effects of percutaneous transluminal angioplasty using the Life Sciences Pulse Volume Recorder, Bruit 6:25-29, June 1982.

86. Gupta, S.K., Veith, F.J., Sprayregen, S. and Samson, RH: Spontaneous resolution of popliteal artery

thrombosis, Arch Surg 116:480-481, April 1981. 87. Veith, F.J., Gupta, S.K., Samson, RH, Flores, S. and Scher, L.A.: Superficial femoral and popliteal

arteries as inflow sites for distal bypasses, Surgery 90:980-990, 1981. 88. Gupta, S.K., Samson, RH, and Veith, F.J.: Embolectomy of the distal part of the popliteal artery,

Surg Gynecol Obstet 153:254-256, 1981.

CURRICULUM VITAE


Page -18-

89. Veith, F.J., Gupta, S.K., Samson, RH, et al: Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures, Ann Surg 194:386-401, 1981.

90. Carnevale, N., Samson, RH, and Bennett, B.P.: Multiple parathyroid adenomas, the surgical

approach, JAMA 246:1332-1334, 1981. 91. Samson, RH, Gupta, S.K., and Veith, F.J.: Preoperative localization of the greater saphenous vein: Use

of the portable doppler ultrasound flow detector, Arch Surg 115:1402, November, 1980. 92. Samson, RH and Pasternak, B.M.: Traumatic arterial spasm-rarity or non-entity, J Trauma 20:607,

July 1980. 93. Samson, RH and Pasternak, B.M.: Current status of surgery of the omentum, Surg Gynecol Obstet

149:437-444, September 1979. 94. Pasternak, B.M., Samson, RH, and Karp, M.D.: Fungal infection of a vascular prosthesis, Surgery

85:586-588, May 1979. 95. Samson, RH and Altman, S.F.: Antibiotic prophylaxis for minor lacerations. Controlled Clinical

Trial, N. Y. State Journal Medicine 77(11): 1728-1730, September 1977. 96. Samson, RH: Residency training and service, New England Journal of Medicine 294:1190, May

1976. 97. Braun, S.A., Samson, RH, Norton, L., and Eiseman, B.: Bile reflux in experimental stress ulcer, Surgery

73:521-524, April 1973. II. LETTERS TO EDITOR AND NON-PEER REVIEWED MATERIAL 1. Samson RH, MOC, Maintenance of Confusion, Editorial Vascular Specialist, September 2016

2. Samson RH, Time to break down the walls, Editorial Vascular Specialist, July 2016

3. Samson RH, Why be a vascular surgeon, Editorial Vascular Specialist, June 2016

4. Samson RH, Disappearing Act, Editorial Vascular Specialist, April 2016

5. Samson RH, Elections, Editorial Vascular Specialist, March 2016

6. Samson RH, Witness, Editorial Vascular Specialist, February 2016

CURRICULUM VITAE


Page -19-

7. Samson RH, Why you need a new SVS tie and scarf, Editorial Vascular Specialist January 2016

8. Samson RH , Mischief maker , Editorial Vascular Specialist December 2015 9. Samson RH , Brothers and Sisters unite , Editorial Vascular Specialist November 2015 10. Samson RH , White Coat Crime , Editorial Vascular Specialist October 2015 11. Samson RH , I’m having an identity crisis , Editorial Vascular Specialist September 2015

12. Samson RH , The Elephant in the operating room , Editorial Vascular Specialist August 2015 13. Samson RH , Medicar- Shared decision making part two , Editorial Vascular Specialist July 2015

14. Samson RH , Knights of the Rectangular Table , Editorial Vascular Specialist June 2015 15. Samson RH , What’s in a name , Editorial Vascular Specialist May 2015 16. Samson RH , Shared Decision making part two , Editorial Vascular Specialist April 2015

17. Samson RH , More on the PAD stenting issue, Editorial Vascular Specialist March 2015 18. Samson RH A new column on Medico-legal issues, Editorial Vascular Specialist February 2015

19. Samson, RH, TLR Target lesion recurrence, Vascular Specialist; January, 2015.

20. Samson, RH, Shared Decision making. Editorial Vascular Specialist; December, 2014.

21. Samson, RH, Why Are We? What Are We?, Editorial, Vascular Specialist; November, 2014.

22. Samson, RH, Last Night I Had a Nightmare, Editorial, Vascular Specialist; October, 2014.

23. Samson, RH, The ‘I’s Have It: Ethics and the3 Vascular Community, Editorial, Vascular

Specialist; August, 2014.

24. Samson, RH, IIb or not IIb?, Editorial, Vascular Specialist; July, 2014.

25. Samson, RH, Just do it?, Editorial, Vascular Specialist; June, 2014.

26. Samson, RH, What Happened to 5 Year Outcomes?; Editorial, Vascular Specialist; May, 2014.

CURRICULUM VITAE


Page -20-

27. Samson, RH, The USPSTF Says Don’t Do It; Editorial, Vascular Specialist; March, 2014

28. Samson, RH, A Band of Brothers and Sisters; Editorial, Vascular Specialist; February, 2014.

29. Samson, RH, Anti-Semantic; Editorial, Vascular Specialist; January 2014.

30. Samson, RH, Invisible Ink; Editorial, Vascular Specialist; December 2013.

31. Samson, RH, SOS: Save the Saphenous Vein Society; Editorial, Vascular Specialist; November, 2013.

32. Samson, RH, Set The Sunshine Act; Editorial, Vascular Specialist; October 2013.

33. Samson, RH, That 5% Thing; Editorial, Vascular Specialist; September 2013.

34. Samson, RH, Support the RUC; Editorial, Vascular Specialist; August 2013.

35. Samson, RH, Welcome To The New Vascular Specialist; Editorial, The Vascular Specialist; July 2013.

36. Samson, RH, Medicare Payments Aim To Be Fair; Sarasota Herald-Tribune Guest Columnist; August 20, 2013; Page A9

37. Samson, RH, Upper Extremity Arterial Problems – Evaluation, Assessment and Diagnosis of Upper Extremity Arterial Problems, Interventions and Therapies, Florida Vascular Foundation Physicians’ Update, Volume 3, 2010:17-19

38. Samson, RH, Obama Misspeaks on Surgeons’ Payment, Letters to the Editor, Sarasota Herald-

Tribune, August 17, 2009 39. Samson, RH, Breakfast Served with a Community Practice Slant, Preview Issue of Vascular

Connections, The Official Newspaper of the Vascular Annual Meeting, June 11-14, 2008, Denver, Colorado

40. Samson, RH, Regarding “Effect of Statins on Renal Function in Patients with Peripheral Arterial

Disease.” Letters to the Editor, Vascular and Endovascular Surgery, December 2008/January 2009 (Vol. 42-6); 620-621

41. Samson, RH, The Passing of Dr. Michael Debakey, Sarasota Herald Tribune, July 15, 2008 42. Samson, RH, The Rational Use of The Noninvasive Vascular Laboratory, Florida Vascular Society

Physicians’ Update, Volume 2, 2008:3-5.

CURRICULUM VITAE


Page -21-

43. Samson, RH, Regarding “Light assisted stab phlebectomy: Report of a technique for removal of lower extremity varicose veins.” Letters to the Editor, J Vasc Surg; Volume 47, Number 4, April 2008; 901-902.

44. Samson, RH, Plasma Lipid Profiles Can Be Measured on a Full Stomach, Evidence Suggested, Vascular

Specialist, Volume 5, Number 9 45. Samson, RH, All in the Family, or a Tale of Two Operations – Patient Survives Two AAA Complications

19 Years Apart, Vascular Specialist, 2007, Volume 5, Number 6 46. Samson, RH, Stopping Statins for Vascular Surgery May Raise Risk , Vascular Specialist, 2007,

Volume 3, Number 6 47. Samson, RH, Novel Drug Might Prevent New-Onset Diabetes, Vascular Specialist, 2007, Volume

3, Number 3 48. Samson, RH, Pfizer Pulls the Plug on Potential Plaque Buster, Vascular Specialist, January/

February 2007, Volume 3, Number 1:5 49. Letters to the Editor, Sarasota Herald-Tribune, July 13, 2001

50. Samson, RH, Consensus Statement on the Investigation of Chronic Venous Insufficiency. On-line

Publication in Circulation. 11/14/2000 51. Samson, RH, Showalter, D.P., Regarding “Popliteal entrapment: more common than previously

recognized.” Letters to the Editors, J Vasc Surg; 31: 1077-1078, 2000 52. Samson, RH: A perspective, randomized trial of Unna’s boot versus Duoderm CGF hydroactive

dressing plus compression in the management of venous leg ulcers. To the Editors: J Vas Surg; 16:500-501, 1992

III. BOOKS AND PERIODICALS

1. Guest Editor for Seminars in Vascular Surgery, December 2008, Robert B. Rutherford, M.D., Editor,

Kenneth Ouriel, M.D., Associate Editor, W.B. Saunders Company, Publishers 2. Assistant Editor – Vascular Surgery, 6th Edition, Edited by Robert B. Rutherford, W.B. Saunders

Company, Publishers 3. Guest Editor for Seminars in Vascular Surgery, December 2002, Robert B. Rutherford, M.D., Editor,

Kenneth Ouriel, M.D., Associate Editor, W.B. Saunders Company, Publishers

CURRICULUM VITAE


Page -22-

IV. BOOK REVIEWS

1. Drugs for the Heart, Journal of Vascular Surgery, July 2005, Volume 42, Number 1, page 184 V. SUBMITTED FOR PUBLICATION

1. Samson, RH, Lepore ML, Non-Invasive Diagnosis of Arterial Disease; Physiological Testing for

Arterial Disease. To be published by Appleton & Davies

VI. ACCEPTED FOR PUBLICATION

1. Samson, RH et al. Five year patency of heparin bonded PTFE outperforms standard PTFE femoropopliteal bypass Journal of Vascular Surgery

SUBMITTED FOR PRESENTATION VIII. CHAPTERS

1. Samson, RH, Nair, D.G. Medical Management of Vascular Disease, ACS Surgery Principles & Practice, In press July 2013.

2. Samson, RH, Morales, L. Improved three year patency rates for heparin-bonded ePTFE femoropopliteal bypass grafts vs. ePTFE grafts without heparin, / BIBA Publishing; Charing Cross Vascular and Endovascular Challenges Update, March 2013, pp 315-320

3. Samson, RH, Medical Management of Carotid Artery Disease, Part V, 4th Edition of Haimovici’s Vascular Surgery, August, 2012. pp 391-404

CURRICULUM VITAE


Page -23-

4. General Surgery Board Review, 4th Edition L Scher, G Weinberg Editors Wolters Kluwer /

Lippincott Williams & Wilkins, Philadelphia, 2012 - Chapter 7 - Peripheral Arterial Disease - LA Scher, NJ Gargiulo, RH Samson ; -

5. General Surgery Board Review, 4th Edition L Scher, G Weinberg Editors Wolters Kluwer /

Lippincott Williams & Wilkins, Philadelphia, 2012, Chapter 8 - Venous and Lymphatic Disease – R.H. Samson, LA Scher

6. Samson, RH Medical Management of Vascular Disease – ACS Surgery Principles & Practice, Chapter 26, 2009

7. Samson, RH, The Role of Statin Drugs in the Management of the Peripheral Vascular Patient – Advances in Vascular Surgery, Volume 12, Edited by Bruce A. Perler, MD, Elsevier, Publishers 2006, pp 77-97

8. Samson, RH, Hypertension and Patients with Vascular Disorders, Assistant Editor – Vascular

Surgery, 6th Edition, Edited by Robert B. Rutherford, W.B. Saunders Company, Publishers 2005, Chapter 39, pp 618-630

9. Samson, RH, Overview: Medical Management in a Vascular Surgery Practice, Assistant

Editor – Vascular Surgery, 6th Edition, Edited by Robert B. Rutherford, W.B. Saunders Company, Publishers 2005, Chapter 35, pp 579-601

10. Samson, RH, Maintaining a Computerized Vascular Registry, Assistant Editor – Vascular

Surgery, 6th Edition, Edited by Robert B. Rutherford, W.B. Saunders Company, Publishers 2005, Chapter 4, pp 31-34

11. Samson, RH, The Arteries and Veins – Optimal Aging Manual, Your Guide from Experts in

Medicine, Law, and Finance, Edited by Kevin W. O’Neil, MD, FACP and Renno L. Peterson, JD, 2004, Chapter 08, pp. 138-155

12. Samson, RH, How to Establish and Maintain a Database, Mansour & Labropoulos: Vascular

Diagnosis, Published by W.B. Saunders Company, 2002 13. Samson, RH, Scher, L.A. & Friedman, S. Peripheral arterial disease. 3rd Edition General

Surgery Board Review, Published by Raven Press, New York, 1998 14. Samson, RH, Pedicled omental flap for cover of exposed artery and other vessels.

Encyclopedia of Flaps. Ed. By Strauch, Bishop, et.al. Published by Little Brown Co., Boston, Vol. 4. 1998

CURRICULUM VITAE


Page -24-

15. Samson, RH and Scher, L.A. Venous and lymphatic disease. 3rd Edition General Surgery Board Review. Published by Raven Press, New York, 1998.

16. Samson, RH and Scher, L.A.: Venous and lymphatic disease. 2nd Edition General Surgery

Board Review. Published by Raven Press, New York, 1993, pp. 95-101. 17. Scher, L.A., Dietzek, A.M. and Samson, RH: Peripheral arterial disease. 2nd Edition General

Surgery Board Review, Ed. Gold, M.S., Scher, L.A. and Weinberg, G. Published by Raven Press, New York, 1993, pp. 79-93

18. Samson, RH: Pedicled omental flap for cover of exposed artery and other vessels. In

Encyclopedia of Flaps. Ed. by Strauch, Bishop, et.al. Published by Little Brown Co., Boston, 1990, Vol. 3:1404-1407.

19. Samson, RH and Scher, L.A.: Venous and lymphatic disease. General Surgery Board Review.

Published by Raven Press, New York, 1986, pp. 69-74. 20. Scher, L.A. and Samson, RH: Peripheral arterial disease. General Surgery Board Review, Ed. Scher,

L.A. and Weinberg, G. Published by Raven Press,New York, 1986, pp.59-68. 21. Scher, L.A., Samson, RH and Veith, F.J.: Aortofemoral and femoropopliteal disease. In

Vascular Surgery: Principles and Practice, Eds. Wilson, S., Veith, F.J., Hobson, R., Williams, R., Published by McGraw-Hill, New York.

22. Samson, RH: Thrombophlebitis. In Surgery of the Adolescent, Ed. by Scott J. Boley and

Michael I Cohen, Published by Grune & Stratton, New York, 1986, pp.83-88. 23. Samson, RH, Scher, L.A. and Veith, F.J.: Combined segment disease. In Butterworths

International Medical Review in Vascular Surgery, Ed. by Peter Bell and Nicholas Tilney, Published by Butterworth & Co., London, 1984, Vol. 4:53-77.

24. Veith, F.J., Gupta, S.K., Weiser, R.K., Flores, S.W., Samson, RH, Scher, L.A. and Ascer, E.: Short

veins grafts in limb salvage arterial reconstruction. In Evaluation and Treatment of Upper and Lower Extremity Circulatory Disorders, by J.J. Bergan and J.S.T. Yao, Published by Grune & Stratton, New York, 1984, P309.

25. Samson, RH, Gupta, S.K., Goldstein,R., Scher, L.A., and Veith, F.J.: Evaluation of peripheral arterial

disease using a transcutaneous oxygen tension sensor. In Proceedings of the 2nd International Symposium on Continuous Transcutaneous Blood Gas Monitoring, Ed. by Renate Huch and Albert Huch, Published by Marcel Dekker, 1983, Vol.5:689-695.

CURRICULUM VITAE


Page -25-

26. Veith, F.J., Gupta, S.K., Samson, RH, Ascer, E., Scher, L.A. and Sprayregen, S.: Femoro- popliteal-tibial occlusive disease. In Review in Vascular Surgery Ed., by Wesley S. Moore, Published by Grune & Stratten, 1983, pp.389-414.

IX. ABSTRACTS AND INVITED CONTRIBUTIONS

1. Samson, R. H., Femoropopliteal bypass is not a generic procedure: technical variations and practice patterns for femoropopliteal bypasses performed by members of the Florida Vascular Society. Cardiovasc. Surg; 12.12: 51-52, ISCVS Abstracts. September 1999

2. Samson, R. H., Showalter, D.P., Yunis, J.P., Dorsay, D. A., Kulman, H.I., Silverman, S.R., Luminal characteristics dictate long-term patency of Polytetrafluoroethylene above-knee prosthetic femoropopliteal bypass grafts. Cardiovasc. Surg; 12.6: 49-50, ISCVS Abstracts. September 1999

3. Samson, RH CD Rom: Reference in Phlebology & Lymphology. Beirsdorf AG

4. Samson, RH and Showalter, D.; Stockings in the prevention of recurrent venous ulcers. PCC Pharmaceutical Communications Company CD on Phlebology in press

5. Samson, RH Compression stockings in non-continuous use of polyurethane foam dressings for the treatment of venous ulceration. PCC Pharmaceutical Communications Company CD on Phlebology in press

6. Walsh J.C., Bergan, J.J., Beeman S., Comer T.P.: Femoral venous reflux abolished by greater saphenous vein stripping. Ann Vasc Surg 1994; 8:566-570. Abstract written by Samson, RH Venous Digest, 2:6:1-2, June 1995.

7. White, R.A., Scher, L.A., Samson, RH and Veith, F.J.: Peripheral vascular injuries associated with falls from heights. 1988 Year Book of Vascular Surgery, Publ. Year Book Medical Publishers, Chicago, 1988, p. 219.

8. Samson, RH, Scher, L.A., Veith, F.J., Ascer, E and Gupta, S.K.: Compression stocking therapy for patients with chronic venous insufficiency (CVI). J Cardiovasc Surg 26:110, September/ October 1985 (Abstract).

9. Ascer, E., Veith, F.J., Lesser, M.L., Morin, L., Gupta, S.K., Scher, L.A., Samson, RH and White-Flores, S.A.: Intraoperative outflow resistance as a predictor of mid-term patency of infrainguinal arterial reconstructions. J Cardiovasc Surg 26:101-102, September/October 1985 (Abstract).

CURRICULUM VITAE


Page -26-

10. Samson, RH, Veith, F.J., Ascer, E., Janko, G.S., Scher, L.A. and Gupta, S.K.: Improved management of infections involving extra-cavitary prosthetic arterial grafts (EPAG). J Cardiovasc Surg 26:83, September/October 1985 (Abstract).

11. Gupta, S.K., Veith,F.J., Ascer, E., Gliedman, M.L., Samson, RH, Scher, L.A. and White-Flores, S.A.: Cost factors in limb-threatening ischemia due to infrainguinal arterio-sclerosis: Is limb salvage worth the expense? J Cardiovasc Surg 26:32, September/October 1985 (Abstract).

12. Veith, F.J., Samson, RH, Ascer, E., Gupta, S.K., White-Flores, S.A., Sprayregen, S., Collier, P. and Scher, L.A.: Tibiotibial vein bypass grafts: A new operation for limb salvage. J. Cardiovasc Surg 26:29-30, September/ October 1985 (Abstract).

13. Gupta, S.K., Scher, L.A., Veith, F.J., White-Flores, S.A., Rivers, S. Sprayregen, S., Samson, RH and Ascer, E.:Limb loss with patent infrainguinal arterial reconstructions: A partially unresolved problem in limb salvage surgery. J. Cardiovasc Surg 26:29, September/October 1985 (Abstract).

14. Weiner, S.N., Scher, L.A., Samson, RH and Veith, F.J.: Radiologic evaluation and surgical correction of angioaccess complications. J Cardiovasc Surg 26:27, September/October 1985 (Abstract).

15. Samson, RH: Letter to the Editor on Transcutaneous PTCO2. Ann Surg 202:130, July 1985.

16. Samson, RH: Impact of cost containment legislation and DRG’s on the future of the vascular laboratory-participant. Vascular Laboratory Review – Special DRG issue 5-39, October 1984.

17. Samson, RH: Protocol for the management of unsuccessful percutaneous transluminal angioplasties. Surgical Practice News 5:14, June 1984.

18. Samson, RH: Discussion on transcutaneous oxygen tension measurements. J Vasc Surg 1:370-371, March 1984.

19. Ascer, E., Veith, F.J., Gupta, S.K., White-Flores, S.A., Scher, L.A., Samson, RH, Weiser, R.K. and Morin, L.: Quantitative assessment of outflow resistance in lower extremity arterial reconstructions. Association for Academic Surgery, p. 45, November 1983 (Abstract).

20. Veith, F.J., Gupta, S.K., Samson, RH, Flores, S.W., Janko, G. and Scher, L.A.: Superficial femoral and popliteal arteries as inflow sites for distal bypasses. In 1983 Year Book of Surgery, S.I. Schwartz, Ed., Yearbook Medical Publishers, Inc., Chicago, pp. 310-312, 1983.

21. Samson, RH, Scher, L.A., Gupta, S.K., Ascer, E. and Veith, F.J.: Photoplethysmographic evaluation of external compressive therapy for chronic venous ulceration. J Cardiovasc Surg 24:420, 1983 (Abstract).

CURRICULUM VITAE


Page -27-

22. Veith, F.J., Weiser, R.K., Gupta, S.K., Scher, L.A., Samson, RH, Ascer, E., White-Flores, S.A. and Sprayregen, S.: Diagnosis and management of failing lower extremity arterial reconstructions prior to graft occlusion. Cardiovasc Surg 24:403, 1983 (Abstract).

23. Scher, L.A., Veith, F.J., Samson, RH, Gupta, S.K., White-Flores, S.A., Sprayregen, S. and Ascer, E.: Predictive factors in success or failure of infrapopliteal arterial reconstruction. J Cardiovasc Surg 24:402, 1983 (Abstract).

24. Ascer, E., Gupta, S.K., Veith, F.J., Fell, S.C., Samson, RH, Scher, L.A., White-Flores, S.A. and Sprayregen, S.: Five year experience with axillo-popliteal bypasses for limb salvage. J Cardiovasc Surg 24:382, 1983 (Abstract).

25. Gupta, S.K., Veith, F.J., Samson, RH, Scher, L.A., Ascer, with 867 expanded polytetrafluoroethylene grafts in arterial reconstructions for limb salvage. J Cardiovasc Surg 24:361,1983 (Abstract).

26. Samson, RH: Discussion of transluminal dilation: an alternative: by Johnston et al in Arch Surg 117:1604-1610, 1982.

27. Gupta, S.K., Veith, F.J., Samson, RH, Scher, L.A., Ascer,E. Weiser, R. and White-Flores, S.A.: Cost analysis of operations for infrainguinal arteriosclerosis (IA).Circulation, 11:9, 1982 (Abstract).

28. Samson, RH: Level of amputation after failure of limb salvage procedures. Orthopedic Digest, Pg.15, Oct. 1982.

29. Samson, RH: Book review of noninvasive diagnostic techniques in vascular disease, 2nd Ed., Edited by Bernstein, E.F., Publ. by C.V. Mosby Co., St. Louis, Mo. PACE 5:621, July 1982.

30. Ascer, E., Gupta, S.K., Veith, F.J., Samson, RH, Scher, L.A., and White-Flores, S.A.: Equivalent results with axillo-unifemoral (AUF) and axillo-bifemoral (ABF) bypasses. Circulation, 11:9, 1982 (Abstract).

31. Samson, RH, Gupta, S.K., Scher, L.A. and Veith, F.J.:Perioperative noninvasive hemodynamic indices as predictors of infrainguinal graft patency. Proceedings of the San Diego Symposium on Noninvasive Diagnostic Techniques in Vascular Surgery, 1982 (Abstract).

32. Veith, F.J., Gupta,S.K., Fell, S.C., Samson, RH and Scher,L.A.: Expanded polytetrafluoroethylene grafts in arterial surgery, N.Y. State J Med, 82:333, 1982 (Abstract).

33. Veith, F.J., Gupta, S.K., Samson, RH, Flores, S.W., Janko, G.S. and Scher, L.A.: The superficial femoral and popliteal arteries as inflow sites for distal bypasses. J Cardiovasc Surg 22:603, 1981 (Abstract).

CURRICULUM VITAE


Page -28-

34. Samson, RH, Gupta, S.K., Scher, L.A., Goldstein, R and Veith, F.J.: Evaluation of graft patency using a transcutaneous PO2 sensor. Proceedings of the Annual Meeting of the Association for Academic Surgery, Chicago, Illinois, November 8-11, 1981.

35. Scher, L.A., Veith, F.J., Haimovici, H., Samson, RH and Gupta, S.K.: Staging of arterial complications of cervical Rib: Guidelines for Surgical Management. J Cardiovasc Surg 22:476, 1981 (Abstract).

36. Samson, RH, Cohen, M. and Silverman, R.: Peripheral embolism, In Case Studies In Cardiac Emergencies, Vol.2, No.7, November 1981.

37. Samson, RH, Scher, L.A., Gupta, S.K. and Veith, F.J.: Treatment of limb-threatening ischemia despite a palpable Popliteal Pulse. J Cardiovasc Surg 22:461, 1981 (Abstract)

38. Samson, RH, Scher, L.A., Gupta, S.K. and Veith, F.J.: Level of amputation after failure of limb salvage procedures. In: Proceedings of the International Vascular Symposium, MacMillan Publ. Ltd., London and Basingstoke, 1981 (Abstract).

39. Gupta, S.K., Veith, F.J., Samson, RH and Scher, L.A.: Femoropopliteal bypass to the isolated popliteal segment: Is polytetrafluoroethylene (PTFE) graft acceptable: In: Proceedings of the International Vascular Symposium, MacMillan Publ. Ltd., London and Basingstoke, 1981 (Abstract).

40. Samson, RH, Scher, L.A., Gupta, S.K. and Veith, F.J.: Level of amputation after failure of limb salvage procedures. In: Proceedings of the International Vascular Symposium, MacMillan Publ. Ltd., London and Basingstoke, 1981 (Abstract).

41. Veith, F.J., Gupta, S.K., Scher, L.A., Janko, G.S. and Samson, RH: Four-year experience with expanded polytetra-fluoroethylene (PTFE) grafts in arterial reconstructions for limb salvage. In: Proceedings of the International Vascular Symposium, MacMillan Publ. Ltd., London and Basingstoke, 1981 (Abstract).

42. Scher, L.A., Gupta, S.K., Samson, RH and Veith, F.J.: Vascular reconstructive surgery and recent myocardial infarction. In: Proceedings of the International Vascular Symposium, MacMillan Publ. Ltd., London and Basingstoke, 1981 (Abstract).

43. Veith, F.J., Gupta, S.K., Samson, RH, Daly, V., Fell, S.C., Estrin, I., Underwood, P, Weiss, P. and Sprayregen,S.: When to stop - The limits of limb salvage. Proceedings of The Eight Annual UCLA Symposium on Vascular Surgery, Palm Springs, California, March 19-23, 1980, p.179 (Abstract).

44. Samson, RH, and Altman, S.F.: Antibiotics shouldn’t be used routinely in minor lacerations, Family Practice News 8(5):34, March 1978

45. Samson, RH, and Deutsch, H.: A manual for foreign medical graduates,” Publ., PNHA and Roche Pharmaceutical, 1977

CURRICULUM VITAE


Page -29-

X. COMMENTARIES / PERSPECTIVES

1. Nonpayment Fails for Infection Rates, Vascular Specialist, Volume 8, No. 6, Page 6, November 2012

2. Outpatient Endovascular Suites: Are They Good for the Patient or the Doctor?, Vascular Specialist, August 2012

3. Vascular Specialist Volume 8, Number 3, May 2012, Page 21, Perspective on Stents Fixed Dialysis Graft / Fistula Pseudoaneurysms

4. Vascular Specialist Volume 8, Number 2, March 2012, Page 5, Perspective on New Anticoagulants Promising but Problematic

5. Vascular Specialist Volume 8, Number 2, March 2012, Page 8, Perspective on Benchmarks

Cited for In-Hospital VTE Post Arthroplasty

6. Vascular Specialist Volume 7, Number 3, May 2011, Page 11, Perspective on Venous Surgery Compared to ‘Conservative’ Therapy

7. SVS Vascular Specialist Online Edition, December 22, 2010, Commentary on Doctors Don’t Agree on How to Reform Medicare Payment

8. Vascular Specialist Volume 6, Number 6, November 2010, Page 14, Perspective on

Dabigatran Approved for AF Stroke Risk

9. Perspectives in Vascular Surgery and Endovascular Therapy, Volume 29, Number 3, September 2007, Page 246. Should Statins be Given Routinely Before Carotid Endarterectomy? Perler, BA

10. Perspectives in Vascular Surgery and Endovascular Therapy, Volume 17, Number 1, March 2005. Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease: Randomized and Observational Comparisons of Secondary Prevention Trials and Their Meta-analyses. Hennekens CH, Sacks, FM, Tonkin A, et al. Arch Intern Med 2004;164:40-44

INTERNATIONAL PRESENTATIONS

CURRICULUM VITAE


Page -30-

1. Pathophysiology of Compression stockings in the management of Chronic venous insufficiency; Invited speaker, Southern Association for Vascular Surgery, Cancun, Mexico January 20th, 2016

2. Outpatient Interventional Center with Vascular Surgery, Interventional Radiology and Cardiology;

Invited speaker,

3. Heparin bonded ePTFE outperforms standard ePTFE in the long term. Southern Association for Vascular Surgery, Cancun, Mexico January 20th, 2016

4. Moderator, GORE Satellite presentations, 37th Charing Cross Symposium, April 30th, 2015; London, England

5. Heparin bonding benefits superficial femoral artery PTFE bypass results. For the motion37th . Invited Speaker Charing Cross Symposium, April 30th, 2015; London, England

6. “The Basil Trial has demonstrated that an endovascular first approach for infrainguinal

revascularization of critical limb ischemia has equal outcomes to open repair. This is also considered to be true for infragenicular and distal tibial arterial disease.” Invited Speaker World Federation of Vascular Societies Congress 2014; October 2-5, 2014; Stellensboch – Western Cape, South Africa

7. Axillo-femoral grafts: Improved results in the modern era. Invited Speaker World Federation of Vascular Societies Congress 2014; October 2-5, 2014; Stellensboch – Western Cape, South Africa

8. The Disadvantaged Saphenous Vein, Invited Speaker National Capital Vascular Symposium, May 10, 2014; Ottawa, Canada

9. Improved Results with Axillofemoral Bypasses in the Modern Era, Invited Speaker National Capital Vascular Symposium, May 10, 2014; Ottawa, Canada

10. 4-year Patency Results of Heparin-bonded ePTFE vs Standard ePTFE, Invited Speaker 36th Charing Cross Symposium, April 5 - 8, 2014; London, England

11. Moderator, GORE Satellite presentations, 36th Charing Cross Symposium, April 6-9, 2013; London, England

12. 3-year Patency Results of Heparin-bonded ePTFE vs Standard ePTFE, Invited Speaker 35th Charing Cross Symposium, April 6-9, 2013; London, England

CURRICULUM VITAE


Page -31-

13. Moderator, GORE Satellite presentations, 35th Charing Cross Symposium, April 6-9, 2013; London, England

14. Duplex Criteria for Selection of Candidates for Superficial Venous Ablation, 2nd Endovascular Panamerican Congress, November 6, 2009 - Rio de Janeiro, Brazil – Invited Speaker

15. Management of Venous Disease – 2nd Endovascular Panamerican Congress, November 6, 2009 -

Rio de Janeiro, Brazil - Moderator 16. Outpatient Endovascular Procedures in a Free-Standing Facility: Good for the Patients and

Doctors, 2nd Endovascular Panamerican Congress, November 6, 2009 - Rio de Janeiro, Brazil – Invited Speaker

17. Cryoplasty versus Plain Old Balloon Angioplasty: Two-Year Data, 2nd Endovascular Panamerican

Congress, November 7, 2009 - Rio de Janeiro, Brazil – Invited Speaker 18. Vascular Challenge – 2nd Endovascular Panamerican Congress, November 7, 2009 - Rio de Janeiro,

Brazil - Panelist 19. Femoropopliteal bypass is not a generic procedure. A survey of the practice patterns of The

Florida Vascular Society - International Society for Cardiovascular Surgery, September 23, 1999 - Melbourne, Australia

20. Luminal characteristics dictate long-term patency of Polytetrafluoroethylene above knee

prosthetic femoropopliteal bypass grafts. - International Society for Cardiovascular Surgery, September 23, 1999 - Melbourne, Australia

21. Vascular Registries – The Industrial Aspects – European Society for Vascular Surgery, XIII Annual

Meeting - September 3, 1999 –Copenhagen, Demark – Invited Speaker 22. Non-Invasive Diagnosis and Management of the Carotid Artery String - Vascular Society of

Southern Africa Annual Congress - October 5, 1997 - Cape Town, South Africa - Invited Speaker

23. Routine Carotid Endarterectomy Without a Shunt Even in the Presence of a Contralateral Occlusion - 23rd World Congress of the ISCVS - September 22, 1997, London England

24. Duplex Scan Diagnosis of Carotid Artery String Sign May Prevent Unnecessary Surgery - 23rd World Congress of the ISCVS - September 22, 1997, London, England

25. Routine Carotid Endarterectomy Without A Shunt Even In The Presence Of A Contralateral

Occlusion, XXI World Congress of the International Society for Cardiovascular Surgery. Lisbon, Portugal. September 12-15, 1993

CURRICULUM VITAE


Page -32-

26. Percutaneous PAO2 evaluation of vascular reconstructions. Second International Meeting on Percutaneous Oxygen Tension Measurements. Zurich, Switzerland, 1984

27. Photoplethysmographic evaluation of external compressive therapy for chronic venous ulceration.

XVI World Congress of the International Society for Cardiovascular Surgery, Rio De Janeiro, Brazil, September 1983.

28. Predictive factors in success or failure of infrapopliteal arterial reconstruction. XVI World Congress

of the International Society for Cardiovascular Surgery, Rio de Janeiro, Brazil, September 1983. 29. Six-year experience with 920 expanded polytetrafluoroethylene grafts in arterial reconstructions for

limb salvage. XVI World Congress of the International Society for Cardiovascular Surgery. Rio de Janeiro, Brazil, September 1983.

30. Visiting Lecturer, Grand Rounds, University of Witwatersrand Medical School, Johannesburg, South

Africa, April 9, 1983. 31. Percutaneous transluminal angioplasty (PTA): Inadequacy of noninvasive hemodynamic evaluation.

First International Congress - Transluminal Angioplasty, Toulouse, France, January 1983. 32. Changing concepts in extraanatomic bypass. International Vascular Symposium, London, England,

September 1981. 33. Femoropopliteal bypass to the isolated popliteal segment: Is polytetrafluoroethylene (PFTE) graft

acceptable. International Vascular Symposium, London, England, September 1981. 34. Level of amputation after failure of limb salvage procedures. International Vascular Symposium.

London, England, September 1981. 35. Four-year experience with expanded polytetrafluoroethylene (PFTE) grafts in arterial reconstructions

for limb salvage. International Vascular Symposium, London, England, September 1981. 36. Treatment of limb threatening ischemia despite a palpable popliteal pulse. XV World Congress of the

International Society for Cardiovascular Surgery. Athens, Greece, August 1981.

37. Level of amputation following failed infrainguinal bypass performed for limb salvage. XV World Congress of the International Society for Cardiovascular Surgery. Athens, Greece, August 1981.

CURRICULUM VITAE


Page -33-

NATIONAL PRESENTATIONS 1. What questions should you ask when interviewing for a community practice position. Veith 43st

Annual Symposium on Vascular And Endovascular Issues; November 15-19, 2016. Invited Speaker

2. Ezetimibe (Zetia® Lowers LDL-C And Decreases Cardiovascular Death, MI AND Stroke Over Statins

Alone: When Should It Be Given And Why Didn’t The FDA Approve It? Veith 43st Annual Symposium

on Vascular And Endovascular Issues; November 15-19, 2016. Invited Speaker

3. 5 year patency of heparin bonded ePTFE out performs standard ePTFE at the femoropopliteal

segment, Veith 43st Annual Symposium on Vascular And Endovascular Issues; November 15-19,

2016. Invited Speaker

4. The business of vascular Surgery, VAST3, Saratoga Springs, August4-7; Invited Panelist

5. How to build a loyal referral practice, Society for Vascular Surgery Annual meeting, National Harbor

Washington, June 9th, 2016, Invited Speaker

6. Five year evaluation of heparin bonded PTFE: the results, Society for Vascular Surgery Annual

meeting, National Horbour Washington, June 9th, 2016, Gore®Invited Speaker

7. Continuing Academic Contributions in Private Practice, SCVS Bellagio Hotel, Las Vegas March 2016,

Invited speaker

8. Is there still a place for Renal artery stenting?, SCVS Bellagio Hotel, Las Vegas March 2016 Invited

Speaker

9. Visiting Professor , UPMC Division of Vascular Surgery , lecture : Carotid endarterectomy: What you

should not do. March 1st and 2nd , 2016

CURRICULUM VITAE


Page -34-

10. Course director, ISET, Hollywood Florida 2/6-10/2016

11. Sclerotherapy is the gold standard for spider veins: Cutaneous laser has a limited role. ISET,

Hollywood Florida 2/6/2016

12. Medical professionalism in the treatment of varicose and spider veins. ISET Hollywood Florida

2/6/2016

13. Building a successful vascular practice. AVSSAP symposium Detroit, Michigan 1/7/2016

14. What’s new in lipid management; Veith 42st Annual Symposium on Vascular And Endovascular

Issues; November 18-22, 2015. Invited Speaker.

15. Asymptomatic Carotid Stenosis (ACS) up to 80% Is Benign: What about Those Stenoses over 85% -

Especially When Associated with a Contralateral Occlusion: Which ACS Patients Should Be Treated

Invasively and How? Veith 42st Annual Symposium on Vascular And Endovascular Issues; November

18-22, 2015. Invited Speaker.

16. How patients (and their medical doctors) should be aware of unnecessary tests and procedures on

their veins and arteries. Such procedural overuse can harm patients and increase healthcare costs

Veith 42st Annual Symposium on Vascular And Endovascular Issues; November 18-22, 2015. Invited

Speaker.

17. Physician owned endovascular centers. Society for Vascular Surgery 2015 Vascular Annual Meeting;

June 16-20, 2015; Chicago, Il. Invited Speaker.

18. Application of new cholesterol guidelines : Society for Vascular Surgery 2015 Vascular Annual

Meeting; June 16-20, 2015 ; Chicago, Il. Invited Speaker.

CURRICULUM VITAE


Page -35-

19. CBAS technology: Invited speaker, SCVS luncheon sponsored by WL GORE® , Miami, FL March 29,

2015

20. Managing Turf issues, Invited speaker SCVS, Miami, FL April 1st, 2015

21. Finding a Job and negotiating a contract : Invited speaker , SCVS, Miami, FL April 1st, 2015

22. Surgical Bypass Summit, 2014; December 1 – 3, 2014; Phoenix, Arizona. Co-Moderator

23. Bypass in the world of “endovascular first”: How does it fit in today’s algorithm? Surgical Bypass

Summit, 2014; December 1 – 3, 2014; Phoenix, Arizona.

24. What are the advantages to a prosthetic conduit? Surgical Bypass Summit, 2014; December 1 – 3,

2014; Phoenix, Arizona

25. Drug therapy and the impact it has on surgical bypass. Surgical Bypass Summit, 2014; December 1 – 3, 2014; Phoenix, Arizona.

26. How will financial considerations affect future decisions? Surgical Bypass Summit, 2014; December 1 – 3, 2014; Phoenix, Arizona.

27. Exciting new developments in the medical treatment of vascular disease. Veith 41st Annual Symposium on Vascular And Endovascular Issues; November 18-22, 2014. Moderator.

28. Technology and Axillo-Femoral Grafting. Thursday Issue of the 41st Annual Veith Symposium Guide. November 18 – 22, 2014. Invited Speaker

29. 5 Year results with heparin bonded PTFE grafts are better than standard PTFE and may be as good as ASV. Veith 41st Annual Symposium on Vascular And Endovascular Issues; November 18-22, 2014. Invited Speaker

30. Why is axillo-bifemoral bypass the new gold standard – replacing aorto-bifemoral bypass when open surgery is required for aorto-iliac occlusive disease: what are the current indications for not using endovascular treatments? Veith 41st Annual Symposium on Vascular And Endovascular Issues; November 18-22, 2014. Invited Speaker

CURRICULUM VITAE


Page -36-

31. What is the long-term fate of the external carotid artery after CEA?: Why it matters. Veith 41st Annual Symposium on Vascular And Endovascular Issues; November 18-22, 2014. Invited Speaker

32. Use of the noninvasive vascular lab in dialysis access. Veith 41st Annual Symposium on Vascular And Endovascular Issues; November 18-22, 2014. Invited Speaker

33. Building a Successful Vascular Practice; Mote Vascular Foundation 6th Annual Symposium; October 24-26, 2014. Organizer/Speaker

34. Branding Your Practice; Mote Vascular Foundation 6th Annual Symposium; October 24-26, 2014. Organizer/Speaker

35. University Employed or Community Independent; Mote Vascular Foundation 6th Annual Symposium; October 24-26, 2014. Organizer/Speaker

36. Continuing Academic Contributions in Private Practice; Mote Vascular Foundation 5th Annual Symposium; October 24-26, 2014. Organizer/Speaker

37. 4-Year Results of Heparin Bonded PTFE Grafts Are Better Than Standard PTFE Grafts And May Be As Good As Saphenous Vein Grafts. Georgia Vascular Society Second Annual Scientific Sessions; September 13-14, 2014; Greensboro, GA. Invited Speaker.

38. Contract Negotiations: Private Practice; Society for Vascular Surgery 2014 Vascular Annual Meeting; June 5-7, 2014; Boston, MA. Invited Speaker.

39. Ethical Issues Related to Frequency of Procedures; Society for Vascular Surgery 2014 Vascular Annual Meeting; June 5-7, 2014; Boston, MA. Invited Speaker.

40. Axillofemoral and Bifemoral Bypass Revisited: Improved Patency Rates in the Modern Era; Florida Vascular Society 27th Annual Scientific Sessions; May 1, 2014; Palm Beach, FL. Invited Speaker.

41. The Vision For VASCULAR SPECIALIST; Florida Vascular Society 27th Annual Scientific Sessions; May 4, 2014; Palm Beach, FL. Invited Speaker.

42. What’s Academics? Getting them in the mood. IAVS Meeting; University of South Florida; April 3, 2014; Tampa, FL. Invited Speaker.

43. “Funding” Your Research – Time and Dollars / Not Real Grants – Rather, Carving Out Time; IAVS Meeting; University of South Florida; April 3, 2014; Tampa, FL. Invited Speaker.

CURRICULUM VITAE


Page -37-

44. Debate Moderator, Society for Clinical Vascular Surgery, 42nd Annual Symposium; March 18 – 22, 2014, Carlsbad, CA.

45. What VASCULAR SPECIALIST – Our SVS Newspaper – Has Meant To US Vascular Surgeons And What Is Its Future; Veith 40th Annual Symposium on Vascular And Endovascular Issues; November 19 – 23, 2013. Invited Speaker.

46. 4-Year Results of Heparin Bonded PTFE Grafts Are Better Than Standard PTFE Grafts And May Be As Good As Saphenous Vein Grafts; Veith 40th Annual Symposium on Vascular And Endovascular Issues; November 19 – 23, 2013. Invited Speaker.

47. Office Based PAD Labs: How Can They Help Your Practice And What Equipment Is Needed?; Veith 40th Annual Symposium on Vascular And Endovascular Issues; November 19 – 23, 2013. Invited Speaker.

48. Update On New Medications For Treating Lipid Abnormalities; Veith 40th Annual Symposium on Vascular And Endovascular Issues; November 19 – 23, 2013. Invited Speaker.

49. DEBATE: Completion Imaging Is Not Needed After CEA; Veith 40th Annual Symposium on Vascular And Endovascular Issues; November 19 – 23, 2013. Invited Speaker.

50. Contralateral Internal Carotid Occlusion Is Not An Indication For CAS Or Mandatory Shunting With CEA; Veith 40th Annual Symposium on Vascular And Endovascular Issues; November 19 – 23, 2013. Invited Speaker.

51. Building a Successful Vascular Practice; Mote Vascular Foundation 5th Annual Symposium; October 25-27, 2013. Organizer/Speaker

52. Branding Your Practice; Mote Vascular Foundation 5th Annual Symposium; October 25-27, 2013. Organizer/Speaker

53. University Employed or Community Independent; Mote Vascular Foundation 5th Annual Symposium; October 25-27, 2013. Organizer/Speaker

54. Continuing Academic Contributions in Private Practice; Mote Vascular Foundation 5th Annual Symposium; October 25-27, 2013. Organizer/Speaker

55. How to Increase Income and Expand Your Practice Menu; Society for Vascular Surgery Annual Meeting; May 30 – June 1, 2013. Invited Speaker

56. Many Aspects of Vascular Surgery Are Too Specialized and Should Be Restricted to Regional Centers to Improve Outcomes - Against; Society for Vascular Surgery Annual Meeting; May 30 –

CURRICULUM VITAE


Page -38-

June 1, 2013. Invited Speaker

57. The 10 Most Important Papers from 2012 Not in the Journal of Vascular Surgery; Society for Vascular Surgery Annual Meeting; May 30 – June 1, 2013. Invited Discussant

58. Leadership Potential in Vascular Surgery; Society for Vascular Surgery Annual Meeting; May 30 – June 1, 2013. Invited Discussant

59. Debate Moderator, Society for Clinical Vascular Surgery, 41st Annual Symposium; March 12 – 16, 2013, Miami, FL

60. Impact of Uninterrupted Use of Clopidogrel on Postoperative Complications after Extracavitary Vascular Surgical Procedures, Society for Clinical Vascular Surgery, 41st Annual Symposium; March 12 – 16, 2013, Miami, FL, Invited Speaker.

61. Carotid Endarterectomy Contralateral to an Occlusion is Not High Risk Even if Shunts are Not Used, Society for Clinical Vascular Surgery, 41st Annual Symposium; March 12 – 16, 2013, Miami, FL, Invited Speaker.

62. Employment Contracts, Society for Clinical Vascular Surgery, 41st Annual Symposium; March 12 – 16, 2013, Miami, FL, Invited Speaker.

63. Continuing Academic Contributions While in Private Practice, Society for Clinical Vascular Surgery, 41st Annual Symposium; March 12 – 16, 2013, Miami, FL, Invited Speaker.

64. Invited Luncheon Speaker; Houston Aortic Symposium; March 21 – 23, 2013.

65. New Developments in Carotid Disease Treatment and Associated Issues; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

66. Improved 3 Year Patency of Heparin Bonded PTFE Grafts vs. PTFE Grafts Without Heparin; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

67. The New Antithrombotic Drugs: When Should They Be Used and When Shouldn’t They; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

68. What is Happening With the Physician-Industry Relationship In Community Practice?; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

69. How Should We Interrupt the JUPITER Trial Showing The Value of Statins: Has JUPITER Gotten a Bum Rap?; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

CURRICULUM VITAE


Page -39-

70. DEBATE: A Shunt Should Never Be Used During CEA: What Is Required To Use The No-Shunt Technique Safely; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

71. Can Medical Treatments Decrease AAA Growth Rates: Prospects For The Future; 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

72. What Drugs Should We Be Using for DVT Treatment? 39th Annual Veith Symposium, November 14 – 18, 2012, New York, NY; Invited Speaker

73. Fixed vs. Mobile X-Ray for Outpatient Angiography Suites, Society for Vascular Surgery Annual Meeting, June 4-8, 2012, Washington, DC, Invited Speaker

74. Florida Outpatient Vascular Lab Centers, Society for Vascular Surgery Annual Meeting, June 4-8, 2012, Washington, DC, Invited Speaker

75. Branding Your Practice, Society for Vascular Surgery Annual Meeting, June 4-8, 2012, Washington, DC, Invited Speaker

76. Critical Review of the Dalcetrapib Plaque Study, Society for Vascular Surgery Annual Meeting, June 4-8, 2012, Washington, DC, Invited Speaker

77. Medical Ethics and Professionalism, International Vein Congress 10th Annual Meeting, May 31 – June 3, 2012, Miami, FL, Invited Speaker

78. Conducting Offshore Clinical Trials Responsibility, International Vein Congress 10th Annual Meeting, May 31 – June 3, 2012, Miami, FL, Invited Speaker

79. Venous Surgery, Standard of Care Issues, Discussion Panelist, International Vein Congress 10th Annual Meeting, May 31 – June 3, 2012, Miami, FL, Invited Speaker

80. Aspirin Therapy or Venous Disease: Any Data? International Vein Congress 10th Annual Meeting, May 31 – June 3, 2012, Miami, FL, Invited Speaker

81. The Physician-Industry Relationship is Under Assault: What Does the Future Hold, Keynote Address, International Vein Congress 10th Annual Meeting, May 31 – June 3, 2012, Miami, FL, Invited Keynote Speaker

82. Pharmacological Methods to Reduce Aneurysm Growth, The Houston Aortic Symposium, Houston, Texas, March 22- March 24, 2012, Invited Speaker

83. To Be Or Not To Be – Surgeons as Hospital Employees, Society for Clinical Vascular Surgery Meeting, Las Vegas, Nevada, March 14 – March 17, 2012, Invited Speaker

CURRICULUM VITAE


Page -40-

84. Gore Excluder Device with C3 Delivery System From Repositioning to Proper Sizing - Continued

Innovation in EVAR & TEVAR from Gore, Society for Clinical Vascular Surgery Meeting, Las Vegas, Nevada, March 14 – March 17, 2012, Invited Speaker

85. Employment Contracts, Society for Clinical Vascular Surgery Meeting, Las Vegas, Nevada, March 14 – March 17, 2012, Invited Speaker

86. Continuing Academic Contributions While in Private Practice, Society for Clinical Vascular Surgery Meeting, Las Vegas, Nevada, March 14 – March 17, 2012, Invited Speaker

87. Physician-Industry Relations In The Era Of AdvaMed, 38th Annual Veith Symposium, New York, New York, November 16 – November 19, 2011, Invited Speaker

88. The New Antithrombotic Drugs: Is the Hype Justified: Do Vascular Surgeons Need to Use Them and How, 38th Annual Veith Symposium, New York, New York, November 16 – November 19, 2011, Invited Speaker

89. What U.S. Vascular Surgeons Can Do to Survive Under Obamacare, 38th Annual Veith Symposium, New York, New York November 16 – November 19, 2011, Invited Speaker

90. Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index: A Randomized Controlled Trial, Society for Vascular Surgery, Chicago, Illinois, June 15 – June 18, 2011, Invited Speaker

91. Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-Analysis of 11 Randomized Controlled Trials Involving 65,229 Participants, Society for Vascular Surgery, Chicago, Illinois, June 15 – June 18, 2011, Invited Speaker

92. Antiplatelet Therapy, Florida Vascular Society 24th Annual Scientific Sessions, Palm Beach, Florida,

April 23 – May 1, 2011, Invited Speaker

93. Laser Ablation of Saphenous Veins is Negatively Affected by Alteration of the Fiber Tip to Prevent Inadvertent Contact with the Vein Wall, Florida Vascular Society 24th Annual Scientific Sessions, Palm Beach, Florida, April 23 – May 1, 2011, Invited Speaker

94. Midterm Results of the Propaten® Heparin-Bonded EPTFE Graft, Florida Vascular Society 24th

Annual Scientific Sessions, Palm Beach, Florida, April 23 – May 1, 2011, Invited Speaker

95. The Endurant Stent Graft System: Results of the Regulatory Pivotal Study, Florida Vascular Society 24th Annual Scientific Sessions, Palm Beach, Florida, April 23 – May 1, 2011, Invited Speaker

CURRICULUM VITAE


Page -41-

96. Health Care Reform Town Meeting, Society for Clinical Vascular Surgery 2011 Annual Meeting, Orlando, Florida, March 16-19, 2011, Invited Speaker

97. New Anticoagulants and Antiplatelet, Society for Clinical Vascular Surgery 2011 Annual Meeting,

Orlando, Florida, March 16-19, 2011, Invited Speaker

98. Trends, Charges, and Outcomes in Endovascuar Therapy for Peripheral Arterial Disease in Florida, Southern Association for Vascular Surgery 2011 Annual Meeting, January 19-22, 2011, Naples, Florida, Invited Speaker

99. What Will Be Lost By Conflict of Interest Mandates to Separate Practicing Physicians and Surgeons

from Industry? VEITH Symposium, November 17-21, 2010, New York, New York, Invited Speaker 100. How Can Endovascular Procedures Be Done Effectively in a Freestanding Outpatient Facility and

Keep It In the Black - Web Based Presentation, VEITH Symposium, November 17-21, 2010, New York, New York, Invited Speaker

101. Can Medication Stabilize or Reverse Vascular Disease: With Lipid Lowering How Low Should You

Go? VEITH Symposium, November 17-21, 2010, New York, New York, Invited Speaker

102. Antiplatelet Treatment for Secondary Risk Prevention in Vascular Patients: Which Drug, What Does, How Long?, Web-Based Presentation, November 17-21, 2010, New York, New York, Invited Speaker

103. Carotid Screening and Surveillance: Should We Be Doing It? AVID Symposium, November 17-21,

2010, New York, New York, Invited Speaker 104. Is There Still a Role for Physiologically Based Testing Modalities to Diagnose Extremity Artery

Disease? Vascular Ultrasound Conference, August 20-21, 2010, Chattanooga, Tennessee, Invited Speaker

105. Duplex Interpretation Criteria for Visceral Stents, Vascular Ultrasound Conference, August 20-21,

2010, Chattanooga, Tennessee, Invited Speaker

106. Free Carotid Screening - Should be We Be Doing It? For/Against, Vascular Ultrasound Conference, August 20-21, 2010, Chattanooga, Tennessee, Invited Speaker

107. Bringing Your Lab Into the 21st Century, Vascular Ultrasound Conference, August 20-21, 2010,

Chattanooga, Tennessee, Invited Speaker

108. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes, Society for Vascular Surgery, June 9-12, 2010, Boston Massachusetts, Discussant

CURRICULUM VITAE


Page -42-

109. Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery, Society for Vascular Surgery, June 9-12, 2010, Boston Massachusetts, Discussant

110. How to Set Up EMR’s, Society for Vascular Surgery, June 9-12, 2010, Boston Massachusetts, Invited

Speaker

111. Private Practice Perspective on Conflict of Interest Mandates, Society for Vascular Surgery, June 9-12, 2010, Boston Massachusetts, Invited Speaker

112. Setting Up An Outpatient Endovascular Center: An Overview, Society for Vascular Surgery, June 9-

12, 2010, Boston Massachusetts, Invited Speaker and Moderator

113. The Role of Statins in Patients with PAD, Society for Vascular Surgery, June 9-12, 2010, Boston Massachusetts, Invited Speaker

114. Keys to a Successful Practice, Society for Clinical Vascular Surgery, April 7-10, 2010, Scottsdale,

Arizona, Invited Speaker 115. Subintimal Angioplasty of Chronic Total Occlusion in Iliac Arteries: A Safe and Durable Option,

Southern Association for Vascular Surgery, January 20-23, 2010, Bahamas, Discussant 116. Ideal Medical Management of Carotid Disease in 2010, Southern Association for Vascular Surgery,

January 20-23, 2010, Bahamas, Invited Speaker

117. The Practice of Vascular Surgery in the Community, Society for Vascular Surgery Annual Meeting, June 11-14, 2009, Denver, Colorado, Moderator

118. Are Outpatient Procedures the Next Best Option?, Society for Vascular Surgery Annual Meeting,

June 11-14, 2009, Denver, Colorado, Invited Speaker

119. Three of the Most Important Papers not Published in the Journal of Vascular Surgery for 2009, Society for Vascular Surgery Annual Meeting, June 11-14, 2009, Denver, Colorado, Invited Speaker

120. Marketing your Vascular Practice, Society for Vascular Surgery Annual Meeting, June 11-14, 2009,

Denver, Colorado, Invited Speaker

121. Antiplatelet Therapy for Secondary Risk Reduction, Society for Vascular Surgery Annual Meeting, June 11-14, 2009, Denver, Colorado, Invited Speaker

122. Routine Carotid Endarterectomy Without a Shunt Even in the Presence of a Contralateral

Occlusion: a Review of 2027 Procedures, Society for Vascular Surgery Annual Meeting, June 11-14, 2009, Denver, Colorado

CURRICULUM VITAE


Page -43-

123. Evolving Patterns of Vascular Lab Testing in the Hospital and Private Lab Settings, 2009 Society for Vascular Ultrasound Conference, June 11-13, 2009, Denver Colorado, Kerri Ricci, RVT, Russell H. Samson, M.D., Invited Speaker

124. Moderator, The Practice of Vascular Surgery in the Community, Society for Vascular Surgery Annual

Meeting, June 11-14, 2009, Denver, Colorado

125. Moderator, Venous Session, 16th National Noninvasive Diagnosis of Vascular Disease Symposium, St. Louis, Missouri, February 26-28, 2009

126. Wounds Associated with Venous and Lymphatic Insufficiency – Wound/Skin-Specific and Disease

Management, Florida Vascular Society 22nd Annual Scientific Session, April 23-26, 2009, Orlando, FL, Invited Speaker

127. Evolving Patterns of Vascular Lab Testing in the Hospital and Private Lab Settings, Florida Vascular

Society 22nd Annual Scientific Session, April 23-26, 2009, Orlando, FL, Invited Speaker

128. Building a Successful Practice, 2009 Gore Fellows Meeting, Society for Clinical Vascular Surgery 37th Annual Meeting, March 18-21, 2009, Ft. Lauderdale, FL, Invited Speaker

129. Duplex Access Planning and Surveillance, Society for Clinical Vascular Surgery Issues in Dialysis

Access SIG 2009, March 18-21, 2009, Ft. Lauderdale, FL, Invited Speaker

130. How Has the Vascular Lab Evolved Over the Last Decade? 16th National Noninvasive Diagnosis of Vascular Disease Symposium, February 26-28, 2009, St. Louis, Missouri, Invited Speaker

131. Understanding the Pathophysiology of compression garments - How and Why They Work, 16th

National Noninvasive Diagnosis of Vascular Disease Symposium, February 26-28, 2009, St. Louis, Missouri, Invited Speaker

132. Becoming a Freestanding Vascular Hospital: Lessons learned, Trends and Pitfalls, Southern

Association for Vascular Surgery 33rd Annual Meeting, January 14-17, 2009, Tucson, Arizona, Invited Speaker

133. Long-term Safety of Renal Vein Division and Ligation to Expedite Complex Abdominal Aortic

Surgery, Southern Association for Vascular Surgery 33rd Annual Meeting, January 14-17, 2009, Tucson, Arizona, Invited Speaker

134. Cryoplasty Works For Limb Salvage In Patients With Critical Ischemia: The Case Against,

VEITHsymposium 2008, New York, New York, November 19-23, 2008, Faculty/Invited Speaker

CURRICULUM VITAE


Page -44-

135. Evolving Patterns Of Vascular Lab Testing In The Hospital And Private Lab Settings, AVIDsymposium 2008, New York, New York, November 21-22, 2008, Faculty/Invited Speaker

136. Safety Of Performing CEA Without Shunts: Experience In 2,000 Patients And What Are The

Requirements To Do This Safely?, VEITHsymposium 2008, New York, New York, November 19-23, 2008, Faculty/Invited Speaker

137. Schanzer A, Mega J, Meadows J, Samson, RH, Bandyk DF, Conte MS, Risk Stratification in Critical

Limb Ischemia (CLI): Derivation and Validation of a Simplified Model to Predict Amputation-Free Survival (AFS) Using Multi-Center Surgical Outcomes Data; Abstract presented at Society for Vascular Surgery, San Diego, California, June 4-8, 2008

138. Setting up an Imaging Center: Adding CT, MR, and an Outpatient Angiography Suite to Surgeon-

Run Vascular Laboratories, Society for Vascular Surgery, San Diego, California, June 4-8, 2008. Invited Speaker

139. Moderator Alex Chao Scientific Award Session, Society for Vascular Ultrasound, San Diego,

California, June 4-7, 2008. Invited Moderator

140. Venous Coding and Economics of a Venous Practice Talk, Florida Vascular Society, Ponte Vedra, Florida, May 1-4, 2008, Invited Speaker

141. Restenosis Following Cryoplasty of the Superficial Femoral and Popliteal Arteries and Saphenous

Vein Grafts: A 36-Month Kaplan Meier Analysis of a Single Center Experience, Southern Association for Vascular Surgery, Naples, Florida, January 16-19, 2008, Invited Speaker

142. The Evolving Role of Physiologic Testing in Today's Vascular Lab, 18th Advances in Vascular Imaging

and Diagnosis, New York, New York, November 16-17, 2007, Faculty/Invited Speaker

143. Vascular Lab 2008: How to Utilize the Vascular Laboratory and Survive in a Hostile Environment, 18th Advances in Vascular Imaging and Diagnosis, New York, New York, November 16-17, 2007, Faculty/Invited Speaker

144. What Vascular Surgeons Need To Know About Best Medical Treatment in 2007?, 34th Veith

Symposium, New York, New York, November 14-18, 2007. Faculty/Invited Speaker

145. What's Cool About Cryoplasty: 2-1/2 Year Results Based on An Analysis of Treated Lesions, 34th Veith Symposium, New York, New York, November 14-18, 2007. Faculty/Invited Speaker

146. Vascular Lab in 2007: Surviving in a New Environment, Society for Vascular Surgery 30th Annual

Meeting, Baltimore, Maryland, June 7-9, 2007, Invited Speaker

CURRICULUM VITAE


Page -45-

147. Infrainguinal and Iliac Interventions, "Open v. Endovascular - Interventional When, Where, How?", Florida Chapter American College of Surgeons 54th Annual Scientific Meeting, Palm Beach, Florida, May 24-27, 2007, Invited Speaker

148. Moderator - Minimally Invasive Advances in Vascular Surgery - The Endovascular Explosion, Florida

Chapter American College of Surgeons 54th Annual Scientific Meeting, Palm Beach, Florida, May 24-27, 2007, Invited Moderator

149. Can Percutaneous Arterial Interventions Be Performed in the Office?, Fifth International Vein

Congress: In-Office Techniques, Miami, Florida, May 18, 2007, Invited Speaker

150. AneuRx® Migration When Guidelines for Insertion are Strictly Followed, 20th Annual Meeting of the Florida Vascular Society, St. Petersburg, Florida, May 3-6, 2007, Invited Speaker

151. Scientific Session III and IV Moderator, 20th Annual Meeting of the Florida Vascular Society, St.

Petersburg, Florida, May 3-6, 2007, Invited Moderator

152. Upper Extremity Arterial Testing – Indications and Interpretation, 20th Annual Meeting of the Florida Vascular Society, St. Petersburg, Florida, May 3-6, 2007, Invited Speaker

153. Vascular Laboratory in 2007, Southern Association for Vascular Surgery, Puerto Rico, January

17-20, 2007. Invited Speaker

154. Phlebectomy, 33rd Veith Symposium, New York, New York, November 15-19, 2006. Faculty/Invited Speaker

155. Integrating the Vascular Lab into Your Outpatient Clinical Practice: Enhancing the Patient Care

Experience, 33rd Veith Symposium, New York, New York, November 15-19, 2006. Faculty/Invited Speaker

156. Apo A-1 Milano Analogues, Torceptrapib, D-4F and Other HDL Raising Drugs: How Do They Work?

33rd Veith Symposium, New York, New York, November 15-19, 2006. Faculty/Invited Speaker

157. Balancing the Arterial and Venous Practice: How I Do It: How Much Can Be Done Safely in the Office?, 33rd Veith Symposium, New York, New York, November 15-19, 2006. Faculty/Invited Speaker

158. Working in a Multi-Specialty Practice, Society for Clinical Vascular Surgery, Las Vegas, Nevada,

March 10, 2006. Faculty/Invited Speaker

159. What Cardiologists Can Learn from a Vascular Surgeon: The Value of Data, 3rd Annual Cardiovascular KnowledgeCenter Consortium Meeting, St. Augustine, Florida, March 1-2, 2005. Invited Speaker

CURRICULUM VITAE


Page -46-

160. New Developments in Lipid and Medical Management of Vascular Patients: What Every Vascular

Surgeon Should Know, 32nd Veith Symposium, New York, New York, November 17-20, 2005. Invited Speaker

161. An International Experience Using The 980nm Laser: 7,000 Cases, 32nd Veith Symposium, New

York, New York, November 17-20, 2005. Invited Speaker

162. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson, RH, Berman SS. Molecular Therapy for Vein Grafts: Results of the PREVENT III Randomized Trial of Edifoligide for the Prevention of Vein Graft Failure in Limb Salvage Patients, Society for Vascular Surgery’s 2005 Vascular Annual Meeting, Chicago, Illinois, June 18, 2005.

163. Merigliano, K., Samson, RH. Intraluminal Prosthetic Graft Thrombus: A New Sign of Impending Graft

Failure Especially in 8mm Grafts, Society for Vascular Surgery’s 2005 Vascular Annual Meeting, Chicago, Illinois, June 16, 2005. Invited Speaker

164. Role of the Vascular Lab in Radiofrequency and Laser Closure Procedures, Society for Vascular

Ultrasound’s 28th Annual Conference & Exhibition, Chicago, Illinois, June 18, 2005. Invited Speaker

165. Pathophysiology of Venous Hemodynamics, Society for Vascular Ultrasound’s 28th Annual Conference & Exhibition, Chicago, Illinois, June 18, 2005. Invited Speaker

166. Endovascular and Surgical Alternatives for SFA and Popliteal Disease, Boston Scientific’s Regional

Symposium, Baton Rouge, Louisiana, May 26, 2005. Invited Speaker

167. Endovenous Saphenous Ablation for Treatment of Varicose Veins – Is It Better and Does It Avoid Surgery?, 33rd Annual Spring Meeting of the American College of Surgeons, Hollywood, Florida, April 18, 2005. Invited Speaker

168. Compression Alone Will Close Ulcers, But Will It Prevent Recurrences?, Third International Vein

Congress: In-Office Techniques, Miami, Florida, April 14-16, 2005. Invited Speaker

169. Sclerotherapy is the Gold Standard, Cutaneous Laser Has a Limited Role, Third International Vein Congress: In-Office Techniques, Miami, Florida, April 14-16, 2005. Invited Speaker

170. Why Do Compression Hoses Work?, In-Office Techniques, Third International Vein Congress,

Miami, FL, April 14-16, 2005, Invited Speaker

171. Vascular Laboratory Assessment of Upper Extremity Arterial Disorders – Common, Uncommon, & Rare, Florida Vascular Society 18th Annual Scientific Sessions, Orlando, Florida, April 7-10, 2005. Invited Speaker

CURRICULUM VITAE


Page -47-

172. The Morbidity in our Midst: A Mandate for Aggressive Medical Management of PAD, Florida

Vascular Society Nursing Forum, Orlando, Florida, April 7, 2005. Invited Speaker

173. Review of Venous Hemodynamics, 14th National Symposium Noninvasive Diagnosis of Vascular Disease, St. John’s Mercy Medical Center, St. Louis, Missouri, March 4, 2005. Invited Speaker

174. Noninvasive Evaluation of Upper Extremity Arterial Syndromes, 14th National Symposium

Noninvasive Diagnosis of Vascular Disease, St. John’s Mercy Medical Center, St. Louis, Missouri, March 4, 2005. Invited Speaker

175. Updates on Antihypertensives and Lipid Lowering Agents, 29th Annual Meeting Southern

Association for Vascular Surgery, Marco Island, Florida. January 19-22, 2005. Invited Speaker

176. Unusual Diseases of the Arteries: What Should I Know About Them? Vascular Disease Symposium, Jacksonville, Florida. December 4, 2004. Invited Speaker

177. Advances in the Pharmacologic Treatment of Arteriosclerosis: What Does the Future Hold? 31st

Global Veith Symposium, New York, New York. November 18-21, 2004. Invited Speaker

178. Management of Untreated Hypertension in the Vascular Patient – What the Vascular Surgeon Needs to Do About It, 31st Global Veith Symposium, New York, New York. November 18-21, 2004. Invited Speaker

179. Customized Venous Exams for Patients Undergoing Saphenous Vein Ablation Therapy: What the

Surgeon Must Know, 15th Symposium, Advances in Vascular Imaging and Diagnosis, New York, New York. November 19-20, 2004. Invited Speaker

180. Venous Hemodynamics: Effects of Pressure Changes, Incompetence and Obstruction in the Upper

and Lower Extremities. 15th Symposium, Advances in Vascular Imaging and Diagnosis, New York, New York. November 19-20, 2004. Invited Speaker

181. Cryo-Balloon Angioplasty. South Florida Society for Vascular Surgery, Key Largo, Florida, October

29-31, 2004. Invited Speaker

182. Pathophysiology of Compression Stockings. International Vein Congress: In-Office Techniques, Key Biscayne, Florida, April 30 – May 1, 2004. Invited Speaker

183. Sclerotheraphy Techniques for Spider Veins and Reticular Veins: Cutaneous Laser has a Limited

Role. International Vein Congress: In-Office Techniques, Key Biscayne, Florida, April 30 – May 1, 2004. Invited Speaker

CURRICULUM VITAE


Page -48-

184. 17th Annual Meeting of the Florida Vascular Society and Endovascular Symposium, Sarasota, Florida, April 22-25, 2004. Invited Speaker

185. Advanced Endovascular Training course, Houston, Texas, April 1-2, 2004

186. Ideal Protocols for the Vascular Laboratory: What’s Missing and What’s Unnecessary? 32nd Annual Symposium on Vascular Surgery. Sponsored by the Society for Clinical Vascular Surgery, Rancho Mirage, CA, March 10-14, 2004. Invited Speaker

187. AAA Endovascular Graft Training Course, Orlando, Florida, January 8, 2004

188. Duplex Ultrasound Before, During and After Varicose Vein Treatment, 30th Annual Vascular and Endovascular Issues, Techniques and Horizons, Sponsored by Albert Einstein College of Medicine, New York, NY, November 20-23, 2003. Invited Speaker

189. Integrating the Vascular Laboratory to Expand and Enhance Your Practice, 14th Annual Advances in

Vascular Imaging and Diagnosis, Sponsored by Albert Einstein College of Medicine, New York, NY, November 21-22, 2003. Invited Speaker

190. Proven Methods to Expand a Vascular Surgery Practice (Integrating Noninvasive Vascular Testing),

Florida Vascular Society & Suncoast Society of Vascular Technology 2003 Scientific Session, Bonita Springs, Florida, May 4, 2003. Invited Speaker

191. Duplex Ultrasound Before, During and After Varicose Vein Treatment, Florida Vascular Society &

Suncoast Society of Vascular Technology 2003 Scientific Session, Bonita Springs, Florida, May 1, 2003. Invited Speaker

192. New Interventions for the Treatment of Varicose Veins, 31st Annual Symposium on Vascular

Surgery, Society for Clinical Vascular Surgery, Miami Florida, March 7, 2003.

193. Duplex Surveillance for PTFE Grafts – Is It Relevant?, 13th National Symposium - Noninvasive Diagnosis of Vascular Disease, Sponsored by Blood Flow Laboratory and Division of Vascular Surgery, St. Louis, Missouri, March 5, 2003. Invited Speaker

194. Complementary Roles of Physiologic Testing and Direct Imaging Studies, 13th National Symposium -

Noninvasive Diagnosis of Vascular Disease, Sponsored by Blood Flow Laboratory and Division of Vascular Surgery, St. Louis, Missouri, March 5, 2003. Invited Speaker

195. Interventional Management of Varicose Veins, 27th Annual Meeting, The Southern Association for

Vascular Surgery 27th, Loews Ventana Canyon Resort, Tucson, Arizona, January 15-18, 2003. Invited Speaker

CURRICULUM VITAE


Page -49-

196. The Vascular Lab Medical Director: Who is Best Suited and Why? Sponsored by Albert Einstein College of Medicine. Sheraton New York Hotel and Towers, New York City, November 23, 2002. Moderator

197. Evolving Concepts in Duplex Surveillance of Femoropopliteal Prosthetic Bypass Grafts. 13 Annual

Advances in Vascular Diagnostics. Sponsored by Albert Einstein College of Medicine. Sheraton New York Hotel and Towers, New York City, November 22, 2002. Invited Speaker

198. Homocysteine May Be a Risk Factor for the Development of Carotid Artery Restenosis Following

Carotid Endarterectomy. 15th Florida Vascular Society Annual Meeting. The Breakers, Palm Beach, Florida, May 2-5, 2002. Presenter

199. What's New That The Vascular Surgeon Should Know About Lipid Metabolism? 28th Global

Vascular Endovascular Issues Techniques Horizons. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 18, 2001. Invited Speaker

200. The Complimentary Roles of Physiologic Testing and Direct Imaging Studies: How to Make It Work.

28th Global Vascular Endovascular Issues Techniques Horizons. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 16, 2001. Invited Speaker

201. Strategies for Managing The "Duplex Scan" Diagnosis of ICA. 28th Global Vascular Endovascular

Issues Techniques Horizons. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 16, 2001. Invited Speaker

202. Rationale For, How To Do It Efficiently and Benefits Accrued: One Center's Experience. 28th Global

Vascular Endovascular Issues Techniques Horizons. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 16, 2001. Invited Speaker

203. The Place of Sclerotherapy in the Treatment of Varicose Veins and Telangiectasis. 14th Annual

Florida Vascular Society Meeting. Sponsored by the Mayo Foundation, Orlando, Florida, April 19 – 22, 2001. Invited Speaker

204. Carotid Endarterectomy Without A Shunt in the Presence of an Occluded Contralateral Artery:

Short and Long-Term Results. 14th Annual Florida Vascular Society Meeting. Sponsored by the Mayo Foundation, Orlando, Florida, April 19 – 22, 2001. Invited Speaker

205. Screening for Carotid Stenosis – Justification based on Risk Factor Analysis. 14th Annual Florida

Vascular Society Meeting. Sponsored by the Mayo Foundation, Orlando, Florida, April 19 – 22, 2001. Invited Speaker

206. AV Access Symposium – Vascular Access for Hemodialysis, 29th Annual Symposium on Vascular

Surgery. Sponsored by Society for Clinical Vascular Surgery, Boca Raton, Florida, April 4 – 7, 2001. Invited Speaker

CURRICULUM VITAE


Page -50-

207. Improvement in Walking Ability, Ankle Pressure Indices & Quality of Life in Vascular Claudication

Using Intermittent Pneumatic Foot & Calf Compression: A Perspective Randomized Trial with 1 Year Follow-up. 29th Annual Symposium on Vascular Surgery. Sponsored by Society for Clinical Vascular Surgery, Boca Raton, Florida, April 4 – 7, 2001. Discussant

208. The Place of Sclerotherapy in Treatment of Varicose Veins and Telangiectasis. 29th Annual

Symposium on Vascular Surgery. Sponsored by Society for Clinical Vascular Surgery, Boca Raton, Florida, April 4 – 7, 2001. Invited Speaker

209. Management of Carotid Occlusion Diagnoses by Duplex Ultrasound. 12th National Noninvasive

Diagnosis of Vascular Disease Symposium. Sponsored by St. John’s Mercy Medical Center, St. Louis, Missouri, March 8, 2001. Invited Speaker

210. Carotid Screening Programs: Are They Worthwhile? 12th National Noninvasive Diagnosis of

Vascular Disease Symposium. Sponsored by St. John’s Mercy Medical Center, St. Louis, Missouri, March 7, 2001. Invited Speaker

211. The Physiologic Approach in Evaluating Lower Extremity Peripheral Vascular Disease. 12th National

Noninvasive Diagnosis of Vascular Disease Symposium. Sponsored by St. John’s Mercy Medical Center, St. Louis, Missouri, March 7, 2001. Invited Speaker

212. How to Heparinize Selectively for Open AAA Repair: Techniques, Precautions, and Advantages.

27th Global Vascular Endovascular Issues Techniques Horizons. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 19, 2000. Invited Speaker

213. Utilizing Your Computer Registry for Research and Quality Improvement/ Assurance. 11th

Symposium and Workshop on Management & Clinical Issues. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 18, 2000. Invited Speaker

214. Screening for Carotid Stenosis: Justification Based on Risk Factor Analysis. 11th Symposium and

Workshop on Management & Clinical Issues. Sponsored by Montefiore Medical Center. Marriott Marquis, New York City, November 17, 2000. Invited Speaker

215. Wound Care in the New Millennium, Sponsored by Regranex Speakers’ Bureau Program,

Donaldsonville & New Orleans, Louisiana, June 22 & 23, 2000, Invited Speaker

216. The results of the Florida Vascular Society’s Study of Carotid Endarterectomy, Amelia Island, Florida, April 8, 2000, 13th Annual Florida Vascular Society Meeting, Amelia Island, April 6 – 9, 2000

217. Selective non-heparinization decreases blood loss, or time and need for transfusions in elective

aortic aneurysm surgery: a new standard against which endografts should be compared, Amelia Island, Florida, 13th Annual Florida Vascular Society Meeting, Amelia Island, April 6 – 9, 2000

CURRICULUM VITAE


Page -51-

218. A Comparison of Polidocanol Sclerotherapy and Photoderm Light Ablation for the Eradication of Spider Telangiectasia-American Venous Forum, Phoenix, Arizona, February 5, 2000

219. The Natural History of the Contralateral Carotid Artery after Ipsilateral Carotid Endarterectomy-

Southern Association For Vascular Surgery, Discussant, Tucson, Arizona, January 20, 2000 220. Spontaneous Regression of Hemodynamically Significant Early Recurrent Carotid Stenosis (HERS):

When Is Invasive Treatment Required – Twenty-Sixth Annual Symposium on Critical Problems, New Horizons and Techniques in Vascular and Endovascular Surgery – Sponsored by Montefiore Medical Center, The Waldorf-Astoria – New York City, November 21,1999. Invited Speaker

221. The Impact of a Vascular Laboratory Registry on Clinical Practice and Laboratory Productivity: A

Surgeon’s Perspective –The Tenth Anniversary Symposium – Advances in Vascular Diagnosis and Vascular Laboratory Management– Sponsored by Montefiore Medical Center & Albert Einstein College of Medicine, The Waldorf-Astoria – New York City, November 19,1999. Invited Speaker

222. Use of Stockings for Obstetrics and Gynecological patients – St. John’s Hospital, Atlanta, GA, June 9,


223. A Comparison of Polidocanol Sclerotherapy and Photoderm Light Ablation for the Eradication of Spider Telangiectasia-American Venous Forum, Phoenix, Arizona, February 5, 2000

224. Femoropopliteal bypass is not a generic procedure - Florida Vascular Society 12th Annual Meeting –

Loews Hotel, Miami Beach, Florida, May 22, 1999

225. Risk factor analysis increases efficacy of duplex screening programs for carotid plaque - Florida Vascular Society 12th Annual Meeting – Loews Hotel, Miami Beach, Florida, May 21, 1999

226. Data entry and report generation using a computerized vascular laboratory registry – Florida Vascular

Society 12th Annual Meeting – Loews Hotel, Miami Beach, Florida, May 20, 1999, Invited Speaker

227. Developing a computerized vascular registry; Beyond the hardware and software is a system – Noninvasive Diagnosis of Vascular Disease – Hyatt Regency Hotel, St. Louis, Missouri, March 25, 1999, Invited Speaker

228. String sign vs. total occlusion; How do we manage in the vascular lab? – Noninvasive Diagnosis of

Vascular Disease – Hyatt Regency Hotel, St. Louis, Missouri, March 24, 1999, Invited Speaker

229. Proper interpretation of carotid, venous, and peripheral arterial studies – Noninvasive Diagnosis of Vascular Disease – Hyatt Regency Hotel, St. Louis, Missouri, March 23, 1999. Invited Speaker

CURRICULUM VITAE


Page -52-

230. Samson, RH, Showalter, D.P.: Hemodynamically significant early recurrent carotid stenosis: an often self-reversing condition - Southern Association for Vascular Surgery, Naples, Florida, January, 28, 1999

231. Patient data management; a necessity for current clinical practice. How I do it. Progress in

Angioscopy 1998: Minimally Invasive and Endovascular Surgery - Ritz-Carlton Hotel, Boston, Massachusetts, December 7, 1998. Invited Speaker

232. Computers in the Vascular Lab. 9th Symposium on Non-Invasive Vascular Lab Diagnosis – The

Waldorf-Astoria, New York City, New York, November 20, 1998. Invited Speaker

233. Injection Therapy versus Laser Therapy for Spider Telangiectasia: Techniques and Indications for Both Methods. 25th Symposium on critical problems in vascular surgery - The Waldorf-Astoria, New York City, New York, November 20, 1998. Invited Speaker

234. The use of a Computerized Database for Angioaccess Surgery. 2nd Hemoaccess Symposium - The

Waldorf-Astoria, New York City, New York, November 19, 1998 Invited Speaker

235. Jobst ulcer care in the management of venous disease, Curative Health Services, Orlando, Florida, October 4, 1998. Invited Speaker

236. Computers in the Vascular Laboratory. The Value of a Database – The Non-Invasive Vascular

Laboratory: Principles and Practices, Hanover Marriott, Whippany, New Jersey, September 26, 1998. Invited Speaker

237. Carotid endarterectomy without arteriography – a safe approach associated with long-term stroke

prevention. Poster session ISCVS/SVS Annual meeting, San Diego, California, June 7-10, 1998

238. The use of Computers in Hemodialysis. The Second Northeastern Conference on vascular Access for hemodialysis, Grand Hyatt Hotel, New York, New York May 16 1998. Invited Speaker

239. Is Thigh Saphenectomy a Necessary Adjunct to High Ligation and Stab Avulsion Phlebectomy –

Society for Clinical Vascular Surgery – San Diego, CA, April 4, 1998

240. Medical and Compressive Therapy for Chronic Venous Disease and its Complications Dermatology Grand Rounds - University of Florida Division of Dermatology and Cutaneous Surgery - January 29, 1998, Gainesville, FL. Invited Speaker

241. Rational Use of Compression in the treatment of Venous disease and Lymphedema - Art and Science

of Wound Management Symposium - December 5, 1997, Orlando, FL. Invited Speaker

CURRICULUM VITAE


Page -53-

242. Can CEA Be Routinely Performed Without A Shunt Even In The Presence Of A Contralateral ICA Occlusion - 24th Annual Symposium on Current Critical Problems, New Horizons, and Techniques in Vascular and Endovascular Surgery, November 23, 1997, New York, NY. Invited Speaker

243. Carotid Endarterectomy Without a Shunt Even in the Presence of a Contralateral Occlusion - Society

for Vascular Surgery, Boston, Mass, June 1, 1997 – Poster

244. Medical Treatment of Chronic Venous Disease and Complications - Seventh Annual Vascular Conference – Pittsburgh, PA. April 16, 1997. Invited Speaker

245. Routine Carotid Endarterectomy Without a Shunt Even in the Presence of a Contralateral Occlusion -

Florida Vascular Society Meeting, St Petersburg, FL, April 11, 1997

246. Establishing & Maintaining a Vascular Laboratory Patient Data Registry -Florida Vascular Society Meeting, St Petersburg FL, April 10, 1997. Invited Speaker

247. Computerization for the Vascular Laboratory. Tenth Symposium for the Noninvasive Diagnosis of

Vascular Disease, St John’s Mercy Medical Center, St Louis, MO, March 14, 1997. Invited Speaker 248. Duplex Diagnosis of Carotid String Sign. Tenth Symposium for the Noninvasive Diagnosis of Vascular

Disease, St John’s Mercy Medical Center, St Louis MO, March 12, 1997. Invited Speaker

249. Selected Topics Hemo Dialysis at the Twenty Third Annual Symposium on Current Critical Problems, New Horizons and Techniques in Vascular and Endovascular Surgery, New York City, NY, November 1996. Invited Speaker

250. Stockings and the Prevention of Recurrent Venous Ulcers. The Art & Science of Wound Management

Meeting, Tucson, AZ, November 1996

251. Standards of Treatment of Venous Disease - New York Medical Group - New York, NY, November 1996

252. Vascular Surgery in the Age of the Computer, 9th Annual Meeting, Florida Vascular Society, April

12-14, 1996.

253. Micro-Surgical Technique vs. Standard Vein Stripping vs. Injection Therapy. 17th Annual Meeting of the American Association for Medical Transcription, Orlando, Florida, July 27-30, 1995. Invited Speaker

254. Carotid Endarterectomy Without a Shunt. St. Anthony’s Hospital, St. Petersburg, Florida, July 19,


CURRICULUM VITAE


Page -54-

255. Compression Stockings & Non-Continuous Use of Polyurethane Foam Dressings for the Treatment of Venous Ulceration - Long Term Results. Eighth Annual Congress of North American Society of Phlebology. Fort Lauderdale, Florida. February 25-28, 1995.

256. Compression Stockings & Polyurethane Foam Dressings for Treatment of Venous Ulceration.

Advances in Wound Healing and Wound Management. Wailea, Maui, Hawaii. February 23, 1994.

257. Samson, RH, Showalter D.P.; Routine Carotid Endarterectomy Without a Shunt Even in the Presence of a Contralateral Occlusion, XXI World Congress of the International Society for Cardiovascular Surgery. Lisbon, Portugal. September 12-15, 1993

258. Samson, RH, Showalter D.P.: Routine Carotid Endarterectomy Without A Shunt Even In The Presence Of

A Contralateral Occlusion, Florida Vascular Society 1993 Annual Meeting. Amelia Island, Florida. April 29 - May 2, 1993

259. Compression Stockings and Non-Continuous Use of Polyurethane Foam Dressings for the Treatment

of Venous Ulceration - A Pilot Study, North American Society of Phlebology. Lake Buena Vista, Florida. February 24, 1993.

260. South Florida Noninvasive Vascular Society, - Vascular Lab Reimbursement. Ft. Lauderdale, Florida,

June 20, 1992. Invited Speaker

261. Dancing With Your CPT'S: Third Party Problems, Seventh National Noninvasive Diagnosis of Vascular Disease Symposium, St. Louis, April 1991 Invited Speaker

262. American Venous Forum, Ft. Lauderdale, February 1991 Invited Speaker

263. Presentation, Gortex Vascular Symposium, Tampa, Florida, November 1989

264. A new classification and management of extracavitory prosthetic arterial graft infection. Montefiore

Medical Center - Eleventh Annual Symposium on Critical Problems in Vascular Surgery, Grand Hyatt, New York, November 1984.

265. Venographic comparison of venous volume plethysmography and doppler ultrasound in the

diagnosis of deep venous thrombo-phlebitis (DVT). The New York Society for Cardiovascular Surgery, Scientific Program, New York, October 1984.

266. Lecturer - Vascular Surgery, Annual Albert Einstein College of Medicine Surgical Board Review Course,

New York, NY, October 1, 1984.

267. Vascular Surgery Annual Albert Einstein College of Medicine Surgical Board Review Course, New York, NY, September 21, 1984. Invited Speaker

CURRICULUM VITAE


Page -55-

268. Grand Rounds, The Brookdale Hospital Medical Center, Brooklyn, New York, September 20, 1984. Invited Speaker

269. Database for Personal Bibliography. Microcomputers in Surgical Practice - A Hands-On Experience.

Waldorf-Astoria Hotel, New York City, September 14-16, 1984. Invited Speaker

270. Diagnosis of DVT Using The Life Sciences PVR - New Diagnostic Criteria. Society for Noninvasive Technology Annual Meeting, Atlanta, Georgia, June 1984.

271. Venous Valvular Incompetence: Primary, Secondary and Stasis Ulceration, St. Joseph's Hospital and

Medical Center Symposium, New Jersey, May 1984. Invited Speaker

272. Impotence - Noninvasive Screening Algorithm. St. Joseph's Hospital and Medical Center Symposium, New Jersey, May 1984. Invited Speaker

273. Noninvasive hemodynamic evaluation of vascular disease. Spring Conference of the American

Academy of Medical Preventics in New Orleans, May 1984. Invited Speaker

274. Ischemic complications of proximal forearm arterial venous fistulas and grafts. New Jersey Vascular Society Annual Meeting, NJ, March 1984.

275. Does the noninvasive vascular laboratory help in the surgeon in arterial extremity disease?

Montefiore Medical Center - Tenth Annual Symposium on Current Critical Problems in Vascular Surgery, New York, N.Y., November 1983.

276. Lecturer - Vascular Surgery, Annual Albert Einstein College of Medicine Surgical Board Review Course,

New York, NY, November 1983.

277. Use of the computer in vascular surgery, exhibit. American College of Surgeons, 69th Annual meeting, Atlanta, Georgia, 1983.

278. Plethysmographic evaluation of the venous component of human erection. Presented at Surgical

Forum, American College of Surgeons, 69th Annual Clinical Congress, Atlanta, Georgia, October 1983

279. Noninvasive evaluation of peripheral vascular disease - New office and hospital techniques. Guest Lecturer, Vascular Disease Symposium sponsored by Methodist Hospital and Research Foundation, Park Nicollet Medical Center, Minneapolis, Minnesota, September 30 - October 1, 1983. Invited Speaker

280. Photoplethysmographic evaluation of external compressive therapy for chronic venous ulceration.

Society for Noninvasive Technology, June 1983

CURRICULUM VITAE


Page -56-

281. Improved technique for diagnosis of vasculogenic impotence. Society for Noninvasive Technology. San Francisco, California, June 1983.

282. Evaluation of graft patency utilizing ankle brachial pressure index and ankle pulse volume recording

amplitude. Society for Noninvasive Technology, San Francisco, California, June 1983.

283. Panelist - Lower extremity studies. Annual Meeting of the Combined New York Regional and New York Cardiovascular Society, New York, N.Y., May 1983.

284. Management of angioplasty complications, unsuccessful procedures and early and late failures.

Ninth Annual Symposium on Current Critical Problems in Vascular Surgery, New York, N.Y., November 1982.

285. Perioperative noninvasive hemodynamic ankle indices as predictors of infrainguinal graft patency. San Diego Symposium on Noninvasive Diagnostic Techniques in Vascular Disease, San Diego, CA., October 1982.

286. Percutaneous transluminal angioplasty (PTA): Inadequacy of noninvasive hemodynamic evaluation

and management of PTA failures. San Diego Symposium on Noninvasive Diagnostic Techniques in Vascular Disease, San Diego, California, October 1982.

287. Lecturer - Vascular Surgery Annual Albert Einstein College of Medicine Surgical Board Review Course,

New York, N.Y., September 1982.

288. Discussant - Hemodynamic evaluation of angioplasty. Thirteenth Annual Meeting of the North American chapter of the International Society of Cardiovascular Surgery, Boston, Massachusetts, June 1982

289. Evaluation of graft patency using a transcutaneous PO2 sensor. Association of Academic Surgeons,

Chicago 1981.

290. Treatment of limb-threatening ischemia despite a palpable popliteal pulse. Association of Academic Surgeons, Chicago, November 1981.

291. Hemodynamics and evaluation of percutaneous transluminal angioplasty. Society for Noninvasive

Technology, Dallas, Texas, June 1981. LOCAL PRESENTATIONS 1. Update on chronic venous insufficiency, Sarasota Memorial Hospital Grand Rounds October 2015

CURRICULUM VITAE


Page -57-

2. Beware of unnecessary tests and procedures: they can cause harm. Boca Grande , Florida February 9th, 2015.

3. Abdominal Aortic Aneurysms – A Time Bomb In Your Tummy; Sarasota Memorial Hospital’s The Vital “Vascular” in Cardiovascular Lecture Series; April 22, 2014; Sarasota, FL. Invited Speaker.

4. Vascular Surgery in 2014 – What’s In and What’s Out? Sarasota Memorial Hospital Cardiac Summit; March 29, 2014; Sarasota, FL. Invited Speaker.

5. Building a Successful Practice: Overview, Mote Vascular Foundation, Inc. Symposium; Sarasota, FL.; October 26, 2013. Organizer / Speaker

6. Branding Your Practice; Mote Vascular Foundation, Inc. Symposium; Sarasota, FL.; October 27, 2013. Organizer / Speaker

7. Building a Successful Practice: Overview, Mote Vascular Foundation, Inc. Symposium; Sarasota, FL.; November 3, 2012. Organizer / Speaker

8. Branding Your Practice; Mote Vascular Foundation, Inc. Symposium; Sarasota, FL.; November 4, 2012. Organizer / Speaker

9. The Role of Statins, Antiplatelet Agents and the New Anticoagulants in Arterial Disease, Florida Academy of Physician Assistants Annual Conference, Marco Island, FL., August 2012

10. Current Interventions to Prevent Stroke: Surgery, Stents and Medications, Stroke Association of Florida, January 2012

11. Building a Successful Practice: Overview, Mote Vascular Foundation, Inc. Symposium, Sarasota, FL, November 2011

12. Aortic Aneurysms: A Time Bomb in your Tummy?, 600 North Cattlemen Road, Sarasota, Florida, January 15, 2011

13. Managing Your Clinical Data; Setting Up a Registry, The Mote Vascular Foundation Inc. Symposium, Program Director and Organizer, Sarasota, Florida, November 2010

14. Building a Successful Vascular Practice: Overview, The Mote Vascular Foundation Inc. Symposium, Program Director and Organizer, Sarasota, Florida, November 2010

15. Can Medication Prevent Vascular Disease? If So, Which Ones, Sunnyside Village, Sarasota, Florida,

July 6, 2010

CURRICULUM VITAE


Page -58-

16. Can Medication Prevent Vascular Disease? If So, Which Ones? The Sarasota Bay Club, Sarasota, Florida, April 20, 2010

17. Can Medication Prevent Vascular Disease? If So, Which Ones? Boca Grande Community Center, Boca

Grande, Florida, February 15, 2010 18. Aortic Aneurysms: A Time Bomb in Your Tummy? 600 North Cattlemen Road, Sarasota, Florida,

January 16, 2010 19. Building a Successful Vascular Practice: Overview, The Mote Vascular Foundation Inc. Symposium,

Program Director and Organizer, Sarasota, Florida, October 9-10, 2009 20. Managing Your Clinical Data; Setting Up a Registry, The Mote Vascular Foundation Inc. Symposium,

Program Director and Organizer, Sarasota, Florida, October 9-10, 2009

21. Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysms (TAA): Natural History, Diagnosis and Treatment Options, Medtronic AAA CME Dinner Presentation, Palmetto, Florida, July 22, 2009

22. Abdominal Aortic Aneurysm: Natural History, Diagnosis and Treatment Options, Medtronic AAA CME

Dinner Presentation, Sarasota, Florida, July 17,2008

23. P.A.D.: Medication, Stents or Surgery? Sunnyside Assisted Living Facility, Sarasota, Florida, June 17, 2008

24. P.A.D.: Medication, Stents or Surgery? Glenridge on Palmer Ranch Assisted Living Facility, Sarasota,

Florida, June 10, 2008

25. P.A.D.: Medication, Stents or Surgery? 600 North Cattlemen Road, Sarasota, Florida, April 26, 2008

26. Abdominal and Thoracic Aortic Aneurysms – New Paradigms in Treatment. Senior Friendship Center, Sarasota, Florida, April 4, 2008

27. Aortic Aneurysm: A Time Bomb in your Tummy?, 600 North Cattlemen Road, Sarasota, Florida,

January 26, 2008

28. Abdominal Aortic Aneurysm: Natural History, Diagnosis and treatment Options, Sarasota, Florida, January 23,2008

29. AV Fistula: The Best Choice for Hemodialysis Access. The Florida ESRD Network, Sarasota, Florida,

March 25, 2007

30. What’s New With Lipid Management, Statins and Drugs to Raise HDL. Senior Friendship Center, Sarasota, Florida, January 12, 2007

CURRICULUM VITAE


Page -59-

31. Perioperative Management of Patients Undergoing Carotid Endarterectomy and Stents, Abdominal

Aneurysm Surgery Including Endografts, and Peripheral Bypass Surgery and Endovascular Therapies. Sarasota Memorial Hospital Floor Nurses, September 19, 2006

32. Be Vein, Speaking of Women’s Health Symposium, Sarasota, Florida, May 13, 2006 33. Screening for Vascular Disorders, Florida Vascular Society Vascular Disease Symposium, Amelia Island,

Florida, December 10, 2005 34. Unusual Disease of the Arteries, Florida Vascular Society Vascular Disease Symposium, Amelia Island,

Florida, December 10, 2005 35. Role of Cryoplasty in the Treatment of Superficial Femoral Artery Disease, Morton’s of Chicago, Boca

Raton, Florida, November 30, 2005 36. Peripheral Arterial and Venous Disease in Women, Sarasota Memorial Hospital, Sarasota, Florida,

November 12, 2005 37. Primary Prevention of CVD in Women, Sarasota Memorial Hospital, Sarasota, Florida, November 12,

2005 38. Stroke Prevention: Surgery, Stents or Medication, Sarasota Memorial Hospital, Sarasota, Florida, May

25, 2005 39. Stroke Prevention: Surgery, Stents or Medication, Heart & Vascular Institute, Sarasota, Florida, March

26, 2005

40. Pain in the Legs: Vascular Disease or Overwork?, Heart & Vascular Institute, Sarasota, Florida, December 14, 2004

41. PAD – An Overview, Florida Academy of Physician Assistants’ Third West Central Region Quarterly

Meeting, Radisson Lido Beach Resort, Sarasota, FL, October 2, 2004 42. CryoPlasty Procedure – A Single Center Experience, Boston Scientific, Tio Pepe Restaurant, Clearwater,

Florida, August 18, 2004 43. Diabetes and Your Vascular System, Sarasota Memorial Health Care System, February 24, 2003 44. Arterial Disease, Boston Scientific, Mediterraneo’s, Sarasota, Florida, February 18, 2003 45. Management of Abdominal Aortic Aneurysm Patients in the Postoperative Period, Sarasota Memorial

Health Care System, Sarasota, Florida, February 10, 2003

CURRICULUM VITAE


Page -60-

46. Risk Factor Modification for Patients with Peripheral Vascular Disease, Senior Friendship Centers,

Sarasota, Florida, December 13, 2002 47. An Overview of Use of Stents, Stent Grafts and Endovascular Aneurysm Surgery for Arterial Diseases,

Health Care Symposium 2002, Sarasota Memorial Health Care System, Sarasota, Florida, November 13, 2002

48. An Overview of Use of Stents, Stent Grafts and Endovascular Aneurysm Surgery for Arterial Diseases,

Health Care Symposium 2002, Sarasota Memorial Health Care System, Sarasota, Florida, July 19, 2002 49. Physiologic Approach in Evaluating Lower Extremity PVD, Suncoast Society of Vascular Technology 4th

Regional Educational Conference, Sarasota, Florida, October 20, 2001 50. PVD Screening – Justification Based on Risk Factor Analysis, Suncoast Society of Vascular Technology

4th Regional Educational Conference, Sarasota, Florida, October 20, 2001 51. New Methods of Treatment of Abdominal Aortic Aneurysms, Senior Friendship Centers, Sarasota,

Florida, May 18, 2001 52. ASAP (Varicose Vein Treatment), Heart & Vascular Center of Florida, Sarasota, Florida, April 13, 2001 53. Abdominal Aortic Aneurysms, Heart and Vascular Center of Florida, Sarasota, Florida, February 16,

2001 54. Advances in Wound Healing, Regranex, St. Petersburg, Florida, December 5, 2000. 55. Advances in Wound Healing, Wound Care Center, Sarasota, Florida, October 10, 2000. 56. Wound Care in the New Millennium, Bradenton, Florida, June 19, 2000. 57. Wound Care in the New Millennium, Doctors Hospital, Sarasota, Florida, May 31, 2000. 58. Wound Care in the New Millennium, Venice, Florida, May 18, 2000. 59. Diabetes & The Vascular System, Sarasota Memorial Hospital – Diabetes Treatment Services, Sarasota,

Florida, March 27, 2000. 60. Wound Healing – Manasota Podiatry Association, Longboat Key, Florida, March 14, 2000. 61. Taking Healing Into the Next Century (THINC) Ortho-McNeil - “Integrating Innovative Approaches To

Treatment of Chronic Non-Healing Ulcers With Regranex Gel” – Invited Speaker, Medical Directors,

CURRICULUM VITAE


Page -61-

Directors of Nursing, Assistant DON’s and ET Nurses for Manatee County Long Term Care Facilities; Anna Maria Island, Florida, December 2, 1999.

62. Varicose Veins, Spider Veins & Treatments -- Speaker, Board of Nursing, Advanced Medical Seminars,

Inc., Sarasota, FL, November 9, 1999. 63. Chronic Venous Disease - Complications of Diabetes, Wounds and Peripheral Vascular Disease

Symposia – Bradenton, FL, November 17, 1997. 64. Non-Surgical Management of Chronic Venous Disorders and Their Complications - Innovations in

Senior Care Symposia - Sarasota, FL, September 26, 1997. 65. Non-invasive Diagnosis of Carotid String Sign, Suncoast Society of Vascular Technology, Hyatt Regency,

Sarasota FL, May 17, 1997. 66. Computers in the Vascular Lab, Suncoast Society of Vascular Technology, Hyatt Regency, Sarasota, FL,

May 17, 1997. 67. What’s New in Circulation Treatment & Disorders, Senior Friends Medical Center, Sarasota FL,

February 1997. 68. Diabetes and the Vascular System. Sarasota Memorial Hospital Diabetes Center, Sarasota, Memorial

Hospital, October 7, 1996. 69. Speaker - State of the Arts Management of Wounds. Symposia ’96 - innovations in Senior Care, Selby

Botanical Gardens, Sarasota, FL, September 27, 1996. 70. New Advances in Treatment of Varicose Veins and Venus Insufficiency. Grand Rounds, Sarasota

Memorial Hospital, Sarasota, Florida, August 30, 1996. 71. Presentation on Wound Care, Manatee Memorial Hospital, Bradenton, Florida, July 30, 1996. 72. Carotid Endarterectomy without a Shunt. Senior Friendship Center, Sarasota, Florida, March 15, 1996. 73. Types of Venous Disease/Treatment. Sarasota Memorial Hospital Vascular Symposium, Sarasota,

Florida, January 13, 1996. 74. Color Ultrasound Evaluation of the Male Urogenital System. Suncoast Society of Vascular Technology.

Sarasota, Florida, April 12, 1994. 75. Venous Disease. Sarasota Memorial Hospital Wound Care Symposium. Sarasota, Florida, January 8,

1994.

CURRICULUM VITAE


Page -62-

76. Update on Vein Disorders, Sarasota Memorial Hospital, 1993. 77. Trends in Surgical Nursing. Topics for the 90’s. Sarasota Memorial Hospital, February 1992. 78. The Latest Trends in Vascular Surgery. What's New in Vascular Surgery. Med-Surg. Workshop.

Sarasota Memorial Hospital, November 1991. 79. Lecturer - Vascular Surgery Seminar, HCA Doctors Hospital, Sarasota, Florida, August 1989. QUOTED IN PUBLICATION ARTICLES / RESPONSES TO PUBLISHED ARTICLES

1. “Latest Data from Peripheral Trials Presented at CX35”, CX Daily News, pp. 3 – 4, April 2013.

2. New Anticoagulants Promising But Problematic,” Vascular Specialist, April 2012

3. Orlando Sentinel – Doctors: Be Careful About Laser Therapy for Veins – April 1, 2012

4. Vascular Specialist – d-Dimer May Be a Useful Marker of VTE Risk – Perspective, January 2012,

Volume 8, Number 1

5. Scopus Top 10 Cited Articles Published in the Last Five Years – Results of PREVENT III: A Multicenter, Randomized Trial of Edifoligide for the Prevention of Vein Graft Failure in Lower Extremity Bypass Surgery, Conte, MS, Bandyk, DF, Clowes, AW, Samson, RH, JVS Volume 43, Issue 4, 2006, Pages 742-751

6. Vascular Specialist – CMS Issues Final Rule on ACOs – Perspective, November 2011, Volume 7, Number 6

7. Vascular News International – Statins and All-Cause Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65,229 Participants, Issue 51, September 2011, Page 14

8. Vascular News International – Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index: A Randomized Controlled Trial, Issue 51, September 2011, Page 13

9. The Florida State University College of Medicine Regional Campus Review Sarasota, Faculty

Spotlight, Volume VI, Number 1, Summer 2011 10. Vascular Specialist – Rivaroxaban: VTE Prevention Benefit, Bleeding Risk – Perspective, July 2011,

Page 13

CURRICULUM VITAE


Page -63-

11. Vascular Specialist – Clopidogrel Deemed “Safe” in Vascular Surgery – Perspective, January 2011, Page 2

12. Vascular Specialist – Dabigatran Approved for AF Stroke Risk - Perspective, November 2010,

Page 14

13. Vascular Specialist – Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes, August 2010, Page 26

14. Vascular Specialist – Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery,

August 2010, Page 26

15. Vascular Specialist – Conflict of Interest, Says Who? – Comment & Analysis, August 2010, Page 42

16. CardioVascular Business.com - SVS: Conflicts of Interest Reporting Might Actually be More Opaque, June 17, 2010

17. Vascular Specialist – Perspective - Consider the Complications, March 2010, Page 4

18. Vascular Specialist – Editors Share Predictions for Vascular Surgery, January 2010, Page 4

19. Vascular Specialist – Assessment of Lipid Levels Can Be Simplified, January 2010,Page 13

20. Vascular Specialist Online – Plasma Lipid Profiles Can Be Measured on a Full Stomach, Evidence

Suggests, 2009, Volume 5, Number 9 21. Vascular Specialist – Women’s VTE Risk, September 2009, Page 5

22. Caitlin Cox in TCTMD discussed New Data Show Cryoplasty Less Effective Than Previously

Reported regarding the paper, Cryoplasty Therapy of the Superficial Femoral and Popliteal Arteries: A Reappraisal After 44-Months’ Experience published in the Journal of Vascular Surgery, 2008; 48;634-637

23. Drs. Christopher J. White and William A. Gray in The Comprehensive Cardiology and

Interventional Resource discussed Cryoplasty Therapy of the Superficial Femoral and Popliteal Arteries: A Reappraisal After 44-Months’ Experience published in the Journal of Vascular Surgery, 2008; 48;634-637

24. Vascular Specialist – d-Dimer Testing a Flawed Predictor of VTE in Elderly, July/August 2008, Page 7

CURRICULUM VITAE


Page -64-

NEWS ITEMS

1. Dr. Russell Samson was a guest speaker at the recent Vascular and Endovascular Issues Technology and Horizons symposium in New York. The symposium is the largest vascular surgical meeting in the world, with more than 4,000 people attending, including 500 luminaries in vascular surgery from around the world. Samson gave six presentations on vascular surgery. Sarasota Herald Tribune; February 24, 2014

2. Samson was recently appointed clinical professor of surgery at Florida State University Medical School. Sarasota Herald Tribune; February 24, 2014

3. Dr. Russell Samson was an invited speaker at the 39th Annual Society for Clinical Vascular Surgery Symposium. He spoke on “New Anticoagulants and Antiplatelets” and hosted a health care reform town hall meeting. Business People, Herald Tribune.com, April 2011

4. News from the Florida State University College of Medicine Sarasota Regional Campus, 2010

Faculty Achievements, January 2011, Page 5

5. Vascular Specialist Becoming a Familiar Face at Island Clinic, Boca Beacon, February 12, 2010 MEDIA INTERVIEWS

1. Media Interview - Study says crossing legs can increase health risks; MySuncoast.com – WWSB ABC 7; February, 2014.

2. Media Interview - Closet Envy; Style Magazine; February, 2014.

3. Media Interview - Healthy Lifestyles may benefit men with prostate cancer and prior to a diagnosis; MySuncoast.com – WWSB ABC 7; January, 2014.

4. Media Interview - Suncoast residents remember Mandela; MySuncoast.com – WWSB ABC 7; December, 2013.

5. Guest Editorial – Medicare payments aim to be fair – Sarasota Herald Tribune; August 20, 2013.

6. VeinGlobal.com – June 11, 2012, As Office-Based Vein Practices Grow In Popularity, Are There Any Ethical Issues Which Concern You? What Role Does Pharmaceutical Treatment Have In Venous Disease, If Any? International Vein Congress, Miami, FL

CURRICULUM VITAE


Page -65-

7. Trends in Ethics - Providers & Industry Battle with Conflicts of Interest, Cardiovascular Business, September 2010

8. “Ask the Doc” Media Interview with Heidi Godman, News Anchor, WWSB-TV, Sarasota, FL –Medications to Prevent Atherosclerosis, September 8, 2009

9. Interview on the Rick Levin Radio Show, the Voice of Manasota, Channel 1280

10. Media Interview on Blab TV – September 8, 2003, Doctors Rounds, Legs for Life Screening for Doctors Hospital.

11. Media Interview by TV Station WWSB – May 14, 2003 on Free Vascular Screening, Sarasota, Florida.

12. Housecalls, SNN, TV Station 40, Sarasota, FL, June 2001.

13. COMCAST TV Heart Center Surgeon Interview – Treatment of Abdominal Aortic Aneurysms, Sarasota, Florida, March, 2000.

14. Housecalls, SNN, TV Station 40, Sarasota, Florida, April, 2000.

15. Surgery News, Graft Size, Age Most Important Factors in Femoropopliteal Bypass Success – Five Year Study Shows Graft Types Perform Equally Well by Dianna Partie Lange, RN, WebMD Medical News, April, 2000.

16. Housecalls, SNN, TV Station 40, Sarasota, FL, December 2000.

17. Media Interview by TV Station WWSB – December 8, 1999 on New Vascular Surgery Procedure, Sarasota, Florida.

18. Sarasota Herald Tribune and Bradenton Herald Tribune Newspapers release: Sarasota Memorial Hospital News Release – December 1999 –“SMH Procedure Offers Less Invasive Alternative To

Abdominal Surgery” – ANCURE System also provides less risky alternative for patients too frail for conventional surgery.”

19. Sarasota Herald Tribune Newspaper reports: “Easier Artery Repair” during a news conference at Sarasota Memorial Hospital – “Sarasota Memorial Hospital pioneers artery-repair device…the first hospital in the state to use the device since its approval by the U.S. Food and Drug Administration.”

20. Media Interview by TV Station WTSP – December 1999 on New Vascular Surgery Procedure, Sarasota, Florida.

21. Media Interview by TV Station WFLA – December 1999 on New Vascular Surgery Procedure, Sarasota, Florida.

CURRICULUM VITAE


Page -66-

PATENTS Lignosulfonate Based Pharmacologic Agent with Anti-coagulant and Anti-thrombotic Activity.

Inventors: Russell H. Samson, M.D. and John W. Hollis, Jr., M.D. Patent #4,988,799. MEDICAL PRODUCTS - UlcerCare® Jobst - Atrium Registry® - Computer Software - Atrium VasLab® - Computer Software - Atrium Everpoint® - Computer Software - FAST FICS® - Scanlon Industries RESEARCH

1. LEOPARD Trial comparing Endologix vs Gore vs Medtronic vs Cook endografts Local PI. 2015

2. A randomized, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor

with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischaemic stroke in patients with established Peripheral Artery Disease (EUCLID – Examining Use of tiCagreLor in paD). Protocol Version: 22JUN2012. 2012

3. A multi-center, placebo-controlled study to evaluate the safety and efficacy of GSK1278863 vs. placebo in subjects with peripheral artery disease (PAD). 2010

4. KOWA: A Phase IIA Multicenter, Randomized, Double-blind, Placebo-and Active-controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication. 2009

5. Angiotech: A Randomized, single blind trial to assess the effectiveness of maintaining patency and

safety of the Vascular Wrap™ Paclitaxel-Eluting Mesh after surgical implantation with the Lifespan® ePTFE vascular graft in the upper extremity for hemodialysis vascular access. 2008

6. Endurant Stent Graft System US Clinical Study; Perspective, single-arm, nonrandomized, multicenter clinical study to demonstrate that the Endurant Stent Graft System is safe and effective for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms. 2008 – ongoing

7. Clinical Trial RE-COVER: A phase III, randomized, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6

CURRICULUM VITAE


Page -67-

month treatment of acute symptomatic venous thromboembolism, following initial treatment (5-10 days) with a parenteral anticoagulant approved for this indication. 2007-2008

8. Clinical Trial RE-MEDY: A Phase III randomized, multicenter, double-blind, parallel group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150mg bid) compared to warfarin (INR 2.0 – 3.0) for the secondary prevention of venous thromboembolism. 2007-2008

9. A multicenter clinical trial designed to demonstrate the safety and efficacy of the CVRx Rheos

Baroreflex Hypertension Therapy System in patients with stage 2 hypertension that are resistant to full drug therapy. – CVRx, Inc. 2006-2007

10. Phase 3, multi-centre, multi-national, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Alfimeprase in subjects with acute peripheral arterial occlusion (NAPA-3) - Nuvelo. 2006

11. BSC Renaissance Trial: A perspective, multi-center, single arm study evaluating the Express Renal Premounted Stent System in the treatment of atherosclerotic lesions in the aortorenal ostium – Boston Scientific. 2004-2009

12. A Phase II, Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of VLTS-934 in

Subjects with Intermittent Claudication Secondary to Peripheral Arterial Disease – PPD Development, LP. 2003

13. A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of Efficacy

And Safety Of Immune Modulation Therapy In Improving Walking Distance In Patients With Intermittent Claudication Secondary To Peripheral Arterial Disease PPD Development, LP. 2003

14. A Multi Center, Randomized, Open-Label, Two Dose, Comparative, Phase 3 Study to Determine

the Safety and Efficacy of MS-325 – Enhanced MRA in Patients with Known or Suspected Pedal Arterial Disease – EPIX Medical, Inc. 2002

15. A Double Blind, Placebo Controlled, Parallel Group Study of the Effects of Zoniporide on

Perioperative Cardiac Events in High Risk Subjects Undergoing Noncardiac Vascular Surgery – Pfizer. 2002

16. A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex-Vivo

Treatment with CGT003 of Peripheral Vein Grafts in Patients Undergoing Peripheral Arterial Bypass Graft Procedures – Corgentech. 2002-2005

17. A Phase II, Double-Blind, Multicenter, Randomized Clinical Trial of Antrin (motexafin lutetium)

Injection, and Far-Red Light Activation for the Prevention of Restenosis and Primary Treatment of De Novo Atherosclerotic Lesions in the Femoral and Popliteal Arteries – Pharmacyclics, Inc. 2002

CURRICULUM VITAE


Page -68-

18. A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects with

Intermittent Claudication Secondary to Peripheral Arterial Disease - PPD Development, LP. 2002

19. Collagen Vascular Sealant Randomized Trial – Surgical Sealants, Inc. 2000 12/3/2016

Documents

CURRICULUM VITAE Russell H. Samson, M.D., R.V.T., …veinsandarteries.com/cosmetic/cv/cv_samson.pdf · Bronx, New York 1974-1979 - Surgery ... Illuminati, G.; Contributing Author,